1
|
Barua S, Stevens M, Jain P, Matus Vazquez G, Boss L, Muthiah K, Hayward C. A Mock Circulatory Loop Analysis of Cardiorenal Hemodynamics With Intra-Aortic Mechanical Circulatory Support. ASAIO J 2024:00002480-990000000-00528. [PMID: 39052927 DOI: 10.1097/mat.0000000000002277] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/27/2024] Open
Abstract
Type 1 cardiorenal syndrome is associated with significant excess morbidity and mortality in patients with severe acute decompensated heart failure. Previous trials of vasoactive drugs and ultrafiltration have not shown superiority over placebo or intravenous diuretics. Pilot data suggest short-term mechanical support devices may support diuresis in the cardiorenal syndrome. We evaluated the intra-aortic balloon pump (IABP) and a novel intra-aortic entrainment pump (IAEP) in a mock circulation loop (MCL) biventricular systolic heart failure model, to assess impact on renal flow and cardiac hemodynamics. Both devices produced similar and only modest increase in renal flow (IABP 3.3% vs. IAEP 4.3%) and cardiac output, with associated reduction in afterload elastance in the MCL. There were minor changes in coronary flow, increase with IABP and minor decrease with IAEP. Differences in device preload and afterload did not impact percentage change in renal flow with IABP therapy, however, there was a trend toward higher percentage flow change with IAEP in response to high baseline renal flow. The IAEP performed best in a smaller aorta and with more superior positioning within the descending aorta. Demonstrated changes in MCL flow during IAEP were of lower magnitude than previous animal studies, possibly due to lack of autoregulation and hormonal responses.
Collapse
Affiliation(s)
- Sumita Barua
- From the Department of Cardiology, St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia
- School of Medicine, University of New South Wales, Kensington, Australia
- Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia
| | - Michael Stevens
- Graduate School of Biomedical Engineering, University of New South Wales, Kensington, Australia
| | - Pankaj Jain
- Department of Cardiology, Royal Prince Alfred Hospital, Camperdown, Australia
- St Vincent's Centre for Applied Medical Research, School of Medicine, University of New South Wales, Kensington, Australia; and
- Faculty of Medicine and Health, University of Sydney, Camperdown, Australia
| | - Gabriel Matus Vazquez
- Graduate School of Biomedical Engineering, University of New South Wales, Kensington, Australia
| | - Laurence Boss
- Graduate School of Biomedical Engineering, University of New South Wales, Kensington, Australia
| | - Kavitha Muthiah
- From the Department of Cardiology, St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia
- School of Medicine, University of New South Wales, Kensington, Australia
- Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia
| | - Christopher Hayward
- From the Department of Cardiology, St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia
- School of Medicine, University of New South Wales, Kensington, Australia
- Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia
| |
Collapse
|
2
|
Wickramarachchi A, Burrell AJC, Joyce PR, Bellomo R, Raman J, Gregory SD, Stephens AF. Flow capabilities of arterial and drainage cannulae during venoarterial extracorporeal membrane oxygenation: A simulation model. Perfusion 2024:2676591241256502. [PMID: 38783767 DOI: 10.1177/02676591241256502] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/25/2024]
Abstract
BACKGROUND Large cannulae can increase cannula-related complications during venoarterial extracorporeal membrane oxygenation (VA ECMO). Conversely, the ability for small cannulae to provide adequate support is poorly understood. Therefore, we aimed to evaluate a range of cannula sizes and VA ECMO flow rates in a simulated patient under various disease states. METHODS Arterial cannulae sizes between 13 and 21 Fr and drainage cannula sizes between 21 and 25 Fr were tested in a VA ECMO circuit connected to a mock circulation loop simulating a patient with severe left ventricular failure. Systemic and pulmonary hypertension, physiologically normal, and hypotension were simulated by varying systemic and pulmonary vascular resistances (SVR and PVR, respectively). All cannula combinations were evaluated against all combinations of SVR, PVR, and VA ECMO flow rates. RESULTS A 15 Fr arterial cannula combined with a 21 Fr drainage cannula could provide >4 L/min of total flow and a mean arterial pressure of 81.1 mmHg. Changes in SVR produced marked changes to all measured parameters, while changes to PVR had minimal effect. Larger drainage cannulae only increased maximum circuit flow rates when combined with larger arterial cannulae. CONCLUSION Smaller cannulae and lower flow rates could sufficiently support the simulated patient under various disease states. We found arterial cannula size and SVR to be key factors in determining the flow-delivering capabilities for any given VA ECMO circuit. Overall, our results challenge the notion that larger cannulae and high flows must be used to achieve adequate ECMO support.
Collapse
Affiliation(s)
- Avishka Wickramarachchi
- Cardio-Respiratory Engineering and Technology Laboratory, Department of Mechanical and Aerospace Engineering, Monash University, Melbourne, VIC, Australia
| | - Aidan J C Burrell
- Department of Intensive Care, Alfred Hospital, Melbourne, VIC, Australia
- Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, VIC, Australia
| | - Patrick R Joyce
- Department of Intensive Care, Alfred Hospital, Melbourne, VIC, Australia
| | - Rinaldo Bellomo
- Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, VIC, Australia
- Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia
- Department of Intensive Care, Royal Melbourne Hospital, Melbourne, VIC, Australia
- Department of Critical Care, The University of Melbourne, Melbourne, VIC, Australia
| | - Jaishankar Raman
- Cardiothoracic Surgery, University of Melbourne, Austin & St Vincent's Hospitals, Melbourne, VIC, Australia
| | - Shaun D Gregory
- Cardio-Respiratory Engineering and Technology Laboratory, Department of Mechanical and Aerospace Engineering, Monash University, Melbourne, VIC, Australia
| | - Andrew F Stephens
- Cardio-Respiratory Engineering and Technology Laboratory, Department of Mechanical and Aerospace Engineering, Monash University, Melbourne, VIC, Australia
| |
Collapse
|
3
|
Agrafiotis E, Zimpfer D, Mächler H, Holzapfel GA. Review of Systemic Mock Circulation Loops for Evaluation of Implantable Cardiovascular Devices and Biological Tissues. J Endovasc Ther 2024:15266028241235876. [PMID: 38528650 DOI: 10.1177/15266028241235876] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/27/2024]
Abstract
CLINICAL IMPACT On needs-based ex vivo monitoring of implantable devices or tissues/organs in cardiovascular simulators provides new insights and paves new paths for device prototypes. The insights gained could not only support the needs of patients, but also inform engineers, scientists and clinicians about undiscovered aspects of diseases (during routine monitoring). We analyze seminal and current work and highlight a variety of opportunities for developing preclinical tools that would improve strategies for future implantable devices. Holistically, mock circulation loop studies can bridge the gap between in vivo and in vitro approaches, as well as clinical and laboratory settings, in a mutually beneficial manner.
Collapse
Affiliation(s)
| | - Daniel Zimpfer
- Division of Cardiac Surgery, Medical University of Graz, Graz, Austria
| | - Heinrich Mächler
- Division of Cardiac Surgery, Medical University of Graz, Graz, Austria
| | - Gerhard A Holzapfel
- Institute of Biomechanics, Graz University of Technology, Graz, Austria
- Department of Structural Engineering, Norwegian University of Science and Technology, Trondheim, Norway
| |
Collapse
|
4
|
Tran P, Tedesco V, Kiang S, Karnik S, Nguyen D, Frazier OH, Fraser KH, Wang Y. Personalized Numerical Cardiovascular Model with Weight Growth for Evaluating Pediatric Left Ventricular Assist Devices: Derivation from an Experimental Mock Circulatory Loop. Ann Biomed Eng 2024; 52:302-317. [PMID: 37777691 DOI: 10.1007/s10439-023-03376-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2023] [Accepted: 09/24/2023] [Indexed: 10/02/2023]
Abstract
Pediatric patients with heart failure have limited treatment options because of a shortage of donor hearts and compatible left ventricular assist devices (LVADs). To address this issue, our group is developing an implantable pediatric LVAD for patients weighing 5-20 kg, capable of accommodating different physiological hemodynamic conditions as patients grow. To evaluate LVAD prototypes across a wide range of conditions, we developed a numerical cardiovascular model, using data from a mock circulatory loop (MCL) and patient-specific elastance functions. The numerical MCL was validated against experimental MCL results, showing good agreement, with differences ranging from 0 to 11%. The numerical model was also tested under left heart failure conditions and showed a worst-case difference of 16%. In an MCL study with a pediatric LVAD, a pediatric dataset was obtained from the experimental MCL and used to tune the numerical MCL. Then, the numerical model simulated LVAD flow by using an HQ curve obtained from the LVAD's impeller. When the numerical MCL was validated against the experimental MCL, hemodynamic differences ranged between 0 and 9%. These findings suggest that the numerical model can replicate various physiological conditions and impeller designs, indicating its potential as a tool for developing and optimizing pediatric LVADs.
Collapse
Affiliation(s)
- Phong Tran
- Innovative Device and Engineering Applications Laboratory, Texas Heart Institute, Houston, TX, USA
| | - Victor Tedesco
- Innovative Device and Engineering Applications Laboratory, Texas Heart Institute, Houston, TX, USA
| | - Simon Kiang
- Innovative Device and Engineering Applications Laboratory, Texas Heart Institute, Houston, TX, USA
| | - Shweta Karnik
- Bioengineering Department, Georgia Institute of Technology, Atlanta, GA, USA
| | - David Nguyen
- Innovative Device and Engineering Applications Laboratory, Texas Heart Institute, Houston, TX, USA
| | - O H Frazier
- Innovative Device and Engineering Applications Laboratory, Texas Heart Institute, Houston, TX, USA
| | | | - Yaxin Wang
- Innovative Device and Engineering Applications Laboratory, Texas Heart Institute, Houston, TX, USA.
| |
Collapse
|
5
|
Rozencwajg S, Wu EL, Heinsar S, Stevens M, Chinchilla J, Fraser JF, Pauls JP. A mock circulation loop to evaluate differential hypoxemia during peripheral venoarterial extracorporeal membrane oxygenation. Perfusion 2024; 39:66-75. [PMID: 35038287 DOI: 10.1177/02676591211056567] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
INTRODUCTION Peripheral veno-arterial extracorporeal membrane oxygenation (VA ECMO) creates a retrograde flow along the aorta competing with the left ventricle (LV) in the so-called 'mixing zone' (MZ). Detecting it is essential to understand which of the LV or the ECMO flow perfuses the upper body - particularly the brain and the coronary arteries - in case of differential hypoxemia (DH). METHODS We described a mock circulation loop (MCL) that enabled experimental research on DH. We recreated the three clinical situations relevant to clinicians: where the brain is either totally perfused by the ECMO or the LV or both. In a second step, we used this model to investigate two scenarios to diagnose DH: (i) pulse pressure and (ii) thermodilution via injection of cold saline in the ECMO circuit. RESULTS The presented MCL was able to reproduce the three relevant mixing zones within the aortic arch, thus allowing to study DH. Pulse pressure was unable to detect location of the MZ. However, the thermodilution method was able to detect whether the brain was totally perfused by the ECMO or not. CONCLUSION We validated an in-vitro differential hypoxemia model of cardiogenic shock supported by VA ECMO. This MCL could be used as an alternative to animal studies for research scenarios.
Collapse
Affiliation(s)
- Sacha Rozencwajg
- Critical Care Research Group, The Prince Charles Hospital, Brisbane, AU-QLD, Australia
- Sorbonne Université, INSERM, UMRS-1166, ICAN Institute of Cardiometabolism and Nutrition, Medical ICU, Pitié-Salpêtrière University Hospital, Paris, France
| | - Eric L Wu
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, AU-QLD, Australia
- Faculty of Medicine, The University of Queensland, Brisbane, AU-QLD, Australia
| | - Silver Heinsar
- Critical Care Research Group, The Prince Charles Hospital, Brisbane, AU-QLD, Australia
| | - Michael Stevens
- Graduate School of Biomedical Engineering, UNSW Sydney, AU -NSW, Australia
| | - Josh Chinchilla
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, AU-QLD, Australia
| | - John F Fraser
- Critical Care Research Group, The Prince Charles Hospital, Brisbane, AU-QLD, Australia
- Faculty of Medicine, The University of Queensland, Brisbane, AU-QLD, Australia
| | - Jo P Pauls
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, AU-QLD, Australia
- School of Engineering and Built Environment, Griffith University, Southport, AU-QLD, Australia
| |
Collapse
|
6
|
D'Souza GA, Rinaldi JE, Meki M, Crusan A, Richardson E, Shinnar M, Herbertson LH. Using a Mock Circulatory Loop as a Regulatory Science Tool to Simulate Different Heart Failure Conditions. J Biomech Eng 2024; 146:011004. [PMID: 37831143 DOI: 10.1115/1.4063746] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2023] [Accepted: 10/06/2023] [Indexed: 10/14/2023]
Abstract
Mechanical circulatory support (MCS) device therapy is one of the primary treatment options for end-stage heart failure (HF), whereby a mechanical pump is integrated with the failing heart to maintain adequate tissue perfusion. The ISO 14708-5:2020 standard prescribes generic guidelines for nonclinical device evaluation and system performance testing of MCS devices using a mock circulatory loop (MCL). However, the utility of MCLs in premarket regulatory submissions of MCS devices is ambiguous, and the specific disease states that the device is intended to treat are not usually simulated. Hence, we aim to outline the potential of MCLs as a valuable regulatory science tool for characterizing MCS device systems by adequately representing target clinical-use HF conditions on the bench. Target pathophysiologic hemodynamics of HF conditions (i.e., cardiogenic shock (CS), left ventricular (LV) hypertrophy secondary to hypertension, and coronary artery disease), along with a healthy adult at rest and a healthy adult during exercise are provided as recommended test conditions. The conditions are characterized based on LV, aorta, and left atrium pressures using recommended cardiac hemodynamic indices such as systolic, diastolic, and mean arterial pressure, mean cardiac output (CO), cardiac cycle time, and systemic vascular resistance. This study is a first step toward standardizing MCLs to generate well-defined target HF conditions used to evaluate MCS devices.
Collapse
Affiliation(s)
- Gavin A D'Souza
- Division of Applied Mechanics, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD 20993
| | - Jean E Rinaldi
- Division of Applied Mechanics, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD 20993
| | - Moustafa Meki
- Division of Applied Mechanics, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD 20993
| | - Annabelle Crusan
- Circulatory Support Devices Team, Office of Product Evaluation and Quality, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD 20993
| | - Eric Richardson
- Circulatory Support Devices Team, Office of Product Evaluation and Quality, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD 20993
| | - Meir Shinnar
- Circulatory Support Devices Team, Office of Product Evaluation and Quality, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD 20993
| | - Luke H Herbertson
- Division of Applied Mechanics, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD 20993
| |
Collapse
|
7
|
Umo A, Kung EO. A Protocol for Coupling Volumetrically Dynamic In-Vitro Experiments to Numerical Physiology Simulation for a Hybrid Cardiovascular Model. IEEE Trans Biomed Eng 2023; 70:1351-1358. [PMID: 36269903 PMCID: PMC11232494 DOI: 10.1109/tbme.2022.3216542] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
OBJECTIVE The Physiology Simulation Coupled Experiment (PSCOPE) is a hybrid modeling framework that enables a physical fluid experiment to operate in the context of a closed-loop computational simulation of cardiovascular physiology. Previous PSCOPE methods coupled rigid experiments to a lumped parameter network (LPN) of physiology but are incompatible with volumetrically dynamic experiments where fluid volume varies periodically. We address this limitation by introducing a method capable of coupling multi-branch and volumetrically dynamic in-vitro experiments to an LPN. METHODS Our proposed method utilizes an iterative weighted-averaging algorithm to identify the unique solution waveforms for a given PSCOPE model. We confirm the accuracy of these PSCOPE solutions by integrating mathematical surrogates of in-vitro experiments directly into the LPN to derive reference solutions, which serve as the gold standard to validate the solutions obtained from using our proposed method to couple the same mathematical surrogates to the LPN. Finally, we illustrate a practical application of our PSCOPE method by coupling an in-vitro renal circulation experiment to the LPN. RESULTS Compared to the reference solution, the normalized root mean square error of the flow and pressure waveforms were 0.001%∼0.55%, demonstrating the accuracy of the coupling method. CONCLUSION We successfully coupled the in-vitro experiment to the LPN, demonstrating the real-world performance within the constraints of sensor and actuation limitations in the physical experiment. SIGNIFICANCE This study introduces a PSCOPE method that can be used to investigate medical devices and anatomies that exhibit periodic volume changes, expanding the utility of the hybrid framework.
Collapse
|
8
|
Xu KW, Gao Q, Wan M, Zhang K. Mock circulatory loop applications for testing cardiovascular assist devices and in vitro studies. Front Physiol 2023; 14:1175919. [PMID: 37123281 PMCID: PMC10133581 DOI: 10.3389/fphys.2023.1175919] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2023] [Accepted: 04/03/2023] [Indexed: 05/02/2023] Open
Abstract
The mock circulatory loop (MCL) is an in vitro experimental system that can provide continuous pulsatile flows and simulate different physiological or pathological parameters of the human circulation system. It is of great significance for testing cardiovascular assist device (CAD), which is a type of clinical instrument used to treat cardiovascular disease and alleviate the dilemma of insufficient donor hearts. The MCL installed with different types of CADs can simulate specific conditions of clinical surgery for evaluating the effectiveness and reliability of those CADs under the repeated performance tests and reliability tests. Also, patient-specific cardiovascular models can be employed in the circulation of MCL for targeted pathological study associated with hemodynamics. Therefore, The MCL system has various combinations of different functional units according to its richful applications, which are comprehensively reviewed in the current work. Four types of CADs including prosthetic heart valve (PHV), ventricular assist device (VAD), total artificial heart (TAH) and intra-aortic balloon pump (IABP) applied in MCL experiments are documented and compared in detail. Moreover, MCLs with more complicated structures for achieving advanced functions are further introduced, such as MCL for the pediatric application, MCL with anatomical phantoms and MCL synchronizing multiple circulation systems. By reviewing the constructions and functions of available MCLs, the features of MCLs for different applications are summarized, and directions of developing the MCLs are suggested.
Collapse
Affiliation(s)
- Ke-Wei Xu
- Department of Engineering Mechanics, School of Aeronautics and Astronautics, Zhejiang University, Hangzhou, China
| | - Qi Gao
- Department of Engineering Mechanics, School of Aeronautics and Astronautics, Zhejiang University, Hangzhou, China
- *Correspondence: Qi Gao,
| | - Min Wan
- Shandong Institute of Medical Device and Pharmaceutical Packaging Inspection, Jinan, China
| | - Ke Zhang
- Shandong Institute of Medical Device and Pharmaceutical Packaging Inspection, Jinan, China
| |
Collapse
|
9
|
Fresiello L, Muthiah K, Goetschalckx K, Hayward C, Rocchi M, Bezy M, Pauls JP, Meyns B, Donker DW, Zieliński K. Initial clinical validation of a hybrid in silico—in vitro cardiorespiratory simulator for comprehensive testing of mechanical circulatory support systems. Front Physiol 2022; 13:967449. [PMID: 36311247 PMCID: PMC9606213 DOI: 10.3389/fphys.2022.967449] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2022] [Accepted: 09/07/2022] [Indexed: 11/13/2022] Open
Abstract
Simulators are expected to assume a prominent role in the process of design—development and testing of cardiovascular medical devices. For this purpose, simulators should capture the complexity of human cardiorespiratory physiology in a realistic way. High fidelity simulations of pathophysiology do not only allow to test the medical device itself, but also to advance practically relevant monitoring and control features while the device acts under realistic conditions. We propose a physiologically controlled cardiorespiratory simulator developed in a mixed in silico-in vitro simulation environment. As inherent to this approach, most of the physiological model complexity is implemented in silico while the in vitro system acts as an interface to connect a medical device. As case scenarios, severe heart failure was modeled, at rest and at exercise and as medical device a left ventricular assist device (LVAD) was connected to the simulator. As initial validation, the simulator output was compared against clinical data from chronic heart failure patients supported by an LVAD, that underwent different levels of exercise tests with concomitant increase in LVAD speed. Simulations were conducted reproducing the same protocol as applied in patients, in terms of exercise intensity and related LVAD speed titration. Results show that the simulator allows to capture the principal parameters of the main adaptative cardiovascular and respiratory processes within the human body occurring from rest to exercise. The simulated functional interaction with the LVAD is comparable to the one clinically observed concerning ventricular unloading, cardiac output, and pump flow. Overall, the proposed simulation system offers a high fidelity in silico-in vitro representation of the human cardiorespiratory pathophysiology. It can be used as a test bench to comprehensively analyze the performance of physically connected medical devices simulating clinically realistic, critical scenarios, thus aiding in the future the development of physiologically responding, patient-adjustable medical devices. Further validation studies will be conducted to assess the performance of the simulator in other pathophysiological conditions.
Collapse
Affiliation(s)
- Libera Fresiello
- Cardiovascular and Respiratory Physiology, University of Twente, Enschede, Netherlands
- Department of Cardiovascular Sciences, Katholieke Universiteit Leuven, Leuven, Belgium
- *Correspondence: Libera Fresiello,
| | - Kavitha Muthiah
- Department of Cardiology, St Vincent’s Hospital, Sydney, NSW, Australia
| | - Kaatje Goetschalckx
- Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium
| | - Christopher Hayward
- Department of Cardiology, St Vincent’s Hospital, Sydney, NSW, Australia
- Victor Chang Cardiac Research Institute, Sydney, NSW, Australia
| | - Maria Rocchi
- Department of Cardiovascular Sciences, Katholieke Universiteit Leuven, Leuven, Belgium
| | - Maxime Bezy
- Department of Cardiovascular Sciences, Katholieke Universiteit Leuven, Leuven, Belgium
| | - Jo P. Pauls
- School of Engineering, Griffith University, Southport, QLD, Australia
| | - Bart Meyns
- Department of Cardiovascular Sciences, Katholieke Universiteit Leuven, Leuven, Belgium
| | - Dirk W. Donker
- Cardiovascular and Respiratory Physiology, University of Twente, Enschede, Netherlands
- Intensive Care Center, University Medical Center Utrecht, Utrecht, Netherlands
| | - Krzysztof Zieliński
- Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, Warsaw, Poland
| |
Collapse
|
10
|
Cappon F, Wu T, Papaioannou T, Du X, Hsu PL, Khir AW. Mock circulatory loops used for testing cardiac assist devices: A review of computational and experimental models. Int J Artif Organs 2021; 44:793-806. [PMID: 34581613 DOI: 10.1177/03913988211045405] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Heart failure is a major health risk, and with limited availability of donor organs, there is an increasing need for developing cardiac assist devices (CADs). Mock circulatory loops (MCL) are an important in-vitro test platform for CAD's performance assessment and optimisation. The MCL is a lumped parameter model constructed out of hydraulic and mechanical components aiming to simulate the native cardiovascular system (CVS) as closely as possible. Further development merged MCLs and numerical circulatory models to improve flexibility and accuracy of the system; commonly known as hybrid MCLs. A total of 128 MCLs were identified in a literature research until 25 September 2020. It was found that the complexity of the MCLs rose over the years, recent MCLs are not only capable of mimicking the healthy and pathological conditions, but also implemented cerebral, renal and coronary circulations and autoregulatory responses. Moreover, the development of anatomical models made flow visualisation studies possible. Mechanical MCLs showed excellent controllability and repeatability, however, often the CVS was overly simplified or lacked autoregulatory responses. In numerical MCLs the CVS is represented with a higher order of lumped parameters compared to mechanical test rigs, however, complex physiological aspects are often simplified. In hybrid MCLs complex physiological aspects are implemented in the hydraulic part of the system, whilst the numerical model represents parts of the CVS that are too difficult to represent by mechanical components per se. This review aims to describe the advances, limitations and future directions of the three types of MCLs.
Collapse
Affiliation(s)
- Femke Cappon
- Department of Mechanical and Aerospace Engineering, Brunel University London, Uxbridge, UK
| | - Tingting Wu
- Department of Mechanical and Electrical Engineering, Soochow University, Suzhou, China
| | - Theodore Papaioannou
- Biomedical Engineering Unit, First Department of Cardiology, Medical School, National and Kapodistrian University of Athens, Zografou, Greece
| | - Xinli Du
- Department of Mechanical and Aerospace Engineering, Brunel University London, Uxbridge, UK
| | - Po-Lin Hsu
- Department of Mechanical and Electrical Engineering, Soochow University, Suzhou, China
| | - Ashraf W Khir
- Department of Mechanical and Aerospace Engineering, Brunel University London, Uxbridge, UK
| |
Collapse
|
11
|
Agrafiotis E, Geith MA, Golkani MA, Hergesell V, Sommer G, Spiliopoulos S, Holzapfel GA. An active approach of pressure waveform matching for stress-based testing of arteries. Artif Organs 2021; 45:1562-1575. [PMID: 34519059 PMCID: PMC9292962 DOI: 10.1111/aor.14064] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2021] [Revised: 08/11/2021] [Accepted: 08/30/2021] [Indexed: 01/04/2023]
Abstract
BACKGROUND Arterial compliance assists the cardiovascular system with three key roles: (i) storing up to 50% of the stroke volume; (ii) ensuring blood flow during diastole; (iii) dampening pressure oscillations through arterial distension. In mock circulation loops (MCLs), arterial compliance was simulated either with membrane, spring, or Windkessel chambers. Although they have been shown to be suitable for cardiac device testing, their passive behavior can limit stress-based testing of arteries. Here we present an active compliance chamber with a feedback control of variable compliance as part of an MCL designed for biomechanical evaluation of arteries under physiological waveforms. MATERIALS AND METHODS The chamber encloses a piston that changes the volume via a cascaded controller when there is a difference between the real-time pressure and the physiological reference pressure with the aim to equilibrate both pressures. RESULTS The experimental results showed repeatable physiological waveforms of aortic pressure in health (80-120 mm Hg), systemic hypertension (90-153 mm Hg), and heart failure reduced ejection fraction (78-108 mm Hg). Statistical validation (n = 20) of the function of the chamber is presented against compared raw data. CONCLUSION We demonstrate that the active compliance chamber can track the actual pressure of the MCL and balance it in real time (every millisecond) with the reference values in order to shape the given pressure waveform. The active compliance chamber is an advanced tool for MCL applications for biomechanical examination of stented arteries and for preclinical evaluation of vascular implants.
Collapse
Affiliation(s)
| | - Markus A Geith
- Institute of Biomechanics, Graz University of Technology, Graz, Austria
| | - Mohammad A Golkani
- Institute of Automation and Control, Graz University of Technology, Graz, Austria
| | - Vera Hergesell
- Department of Cardiac Surgery, Medical University of Graz, Graz, Austria
| | - Gerhard Sommer
- Institute of Biomechanics, Graz University of Technology, Graz, Austria
| | | | - Gerhard A Holzapfel
- Institute of Biomechanics, Graz University of Technology, Graz, Austria.,Department of Structural Engineering, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
| |
Collapse
|
12
|
Torres DS, Mazzetto M, Cestari IA. A novel automated simulator of pediatric systemic circulation: Design and applications. Biomed Signal Process Control 2021. [DOI: 10.1016/j.bspc.2021.102926] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
13
|
Chen D, Liang S, Li Z, Mei Y, Dong H, Ma Y, Zhao J, Xu S, Zheng J, Xiong J. A Mock Circulation Loop for In Vitro Hemodynamic Evaluation of Aorta: Application in Aortic Dissection. J Endovasc Ther 2021; 29:132-142. [PMID: 34342237 DOI: 10.1177/15266028211034863] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
PURPOSE Aortic dissection (AD) is a catastrophic disease with complex hemodynamic conditions, however, understandings regarding its perfusion characteristics were not sufficient. In this study, a mock circulation loop (MCL) that integrated the Windkessel element and patient-specific silicone aortic phantoms was proposed to reproduce the aortic flow environment in vitro. MATERIALS AND METHODS Patient-specific normal and dissected aortic phantoms with 12 branching vessels were established and embedded into this MCL. Velocities for aortic branches based on 20 healthy volunteers were regarded as the standardized data for flow division. By altering boundary conditions, the proposed MCL could mimic normal resting and left-sided heart failure (LHF) conditions. Flow rates and pressure status of the aortic branches could be quantified by separate sensors. RESULTS In normal resting condition, the simulated heart rate and systemic flow rate were 60 bpm and 4.85 L/minute, respectively. For the LHF condition, the systolic and diastolic blood pressures were 75.94±0.77 mmHg and 57.65±0.35 mmHg, respectively. By tuning the vascular compliance and peripheral resistance, the flow distribution ratio (FDR) of each aortic branch was validated by the standardized data in the normal aortic phantom (mean difference 2.4%±1.70%). By comparing between the normal and dissected aortic models under resting condition, our results indicated that the AD model presented higher systolic (117.82±0.60 vs 108.75±2.26 mmHg) and diastolic (72.38±0.58 vs 70.46±2.33 mmHg) pressures, the time-average velocity in the true lumen (TL; 36.95 cm/s) was higher than that in the false lumen (FL; 22.95 cm/s), and the blood transport direction between the TL and FL varied in different re-entries. CONCLUSIONS The proposed MCL could be applied as a research tool for in vitro hemodynamic analysis of the aorta diseases under various physical conditions.
Collapse
Affiliation(s)
- Duanduan Chen
- School of Life Science, Beijing Institute of Technology, Beijing, China
| | - Shichao Liang
- School of Life Science, Beijing Institute of Technology, Beijing, China
| | - Zhenfeng Li
- School of Life Science, Beijing Institute of Technology, Beijing, China
| | - Yuqian Mei
- School of Life Science, Beijing Institute of Technology, Beijing, China
| | - Huiwu Dong
- Department of Ultrasound Diagnosis, Chinese PLA General Hospital, Beijing, China
| | - Yihao Ma
- The High School Affiliated to Renmin University of China, China
| | - Jing Zhao
- Department of Scientific Research Management, Medical Services Division, Chinese PLA General Hospital, Beijing, China
| | - Shangdong Xu
- Center of Cardiac Surgery, Beijing Anzhen Hospital, Beijing Institute of Heart, Lung and Vascular Diseases, Capital Medical University Beijing Aortic Disease Center, Beijing, China
| | - Jun Zheng
- Center of Cardiac Surgery, Beijing Anzhen Hospital, Beijing Institute of Heart, Lung and Vascular Diseases, Capital Medical University Beijing Aortic Disease Center, Beijing, China
| | - Jiang Xiong
- Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, China.,Department of Vascular and Endovascular Surgery, Hainan Hospital, Chinese PLA General Hospital, Hainan, China
| |
Collapse
|
14
|
Development and Validation of a Life-Sized Mock Circulatory Loop of the Human Circulation for Fluid-Mechanical Studies. ASAIO J 2020; 65:788-797. [PMID: 30281544 DOI: 10.1097/mat.0000000000000880] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023] Open
Abstract
Mock circulatory loops (MCLs) are usually developed for assessment of ventricular assist devices and consist of abstracted anatomical structures represented by connecting tubing pipes and controllable actuators which could mimic oscillating flow processes. However, with increasing use of short-term peripheral mechanical support (extracorporeal life support [ECLS]) and the upcoming evidence of even counteracting flow processes between the failing native circulation and ECLS, MCLs incorporating the peripheral vascular system and preserved anatomical structures are becoming more important for systematic assessment of these processes. For reproducible and standardized fluid-mechanical studies using magnetic resonance imaging, Doppler ultrasound, and computational fluid dynamics measurements, we developed a MCL of the human circulation. Silicon-based life-sized dummies of the human aorta and vena cava (vascular module) were driven by paracorporeal pneumatic assist devices. The vascular module is placed in a housing with all arterial branches merging into peripheral resistance and compliances modules, and blood-mimicking fluid returns to the heart module through the venous dummy. Compliance and resistance chambers provide for an adequate simulation of the capillary system. Extracorporeal life support cannulation can be performed in the femoral and subclavian arteries and in the femoral and jugular veins. After adjusting vessel diameters using variable Hoffmann clamps, physiologic flow rates were achieved in the supraaortic branches, the renal and mesenteric arteries, and the limb arteries with physiologic blood pressure and cardiac output (4 L/min). This MCL provides a virtually physiologic platform beyond conventional abstracted MCLs for simulation of flow interactions between the human circulation and external circulation generated by ECLS.
Collapse
|
15
|
Koh V, Pauls J, Wu E, Stevens M, Ho Y, Lovell N, Lim E. A centralized multi-objective model predictive control for a biventricular assist device: An in vitro evaluation. Biomed Signal Process Control 2020. [DOI: 10.1016/j.bspc.2020.101914] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
16
|
Gregory SD, Pauls JP, Wu EL, Stephens A, Steinseifer U, Tansley G, Fraser JF. An advanced mock circulation loop for in vitro cardiovascular device evaluation. Artif Organs 2020; 44:E238-E250. [PMID: 31951020 DOI: 10.1111/aor.13636] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2019] [Revised: 12/11/2019] [Accepted: 01/07/2020] [Indexed: 11/28/2022]
Abstract
Controlled and repeatable in vitro evaluation of cardiovascular devices using a mock circulation loop (MCL) is essential prior to in vivo or clinical trials. MCLs often consist of only a systemic circulation with no autoregulatory responses and limited validation. This study aimed to develop, and validate against human data, an advanced MCL with systemic, pulmonary, cerebral, and coronary circulations with autoregulatory responses. The biventricular MCL was constructed with pneumatically controlled hydraulic circulations with Starling responsive ventricles and autoregulatory cerebral and coronary circulations. Hemodynamic repeatability was assessed and complemented by validation using impedance cardiography data from 50 healthy humans. The MCL successfully simulated patient scenarios including rest, exercise, and left heart failure with and without cardiovascular device support. End-systolic pressure-volume relationships for respective healthy and heart failure conditions had slopes of 1.27 and 0.54 mm Hg mL-1 (left ventricle), and 0.18 and 0.10 mm Hg mL-1 (right ventricle), aligning with the literature. Coronary and cerebral autoregulation showed a strong correlation (R2 : .99) between theoretical and experimentally derived circuit flow. MCL repeatability was demonstrated with correlation coefficients being statistically significant (P < .05) for all simulated conditions while MCL hemodynamics aligned well with human data. This advanced MCL is a valuable tool for inexpensive and controlled evaluation of cardiovascular devices.
Collapse
Affiliation(s)
- Shaun D Gregory
- Department of Mechanical and Aerospace Engineering, Monash University, Melbourne, VIC, Australia.,Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.,Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia.,School of Engineering and Built Environment, Griffith University, Southport, QLD, Australia.,School of Medicine, University of Queensland, Brisbane, QLD, Australia
| | - Jo P Pauls
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia.,School of Engineering and Built Environment, Griffith University, Southport, QLD, Australia.,School of Medicine, University of Queensland, Brisbane, QLD, Australia
| | - Eric L Wu
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia.,School of Medicine, University of Queensland, Brisbane, QLD, Australia
| | - Andrew Stephens
- Department of Mechanical and Aerospace Engineering, Monash University, Melbourne, VIC, Australia.,Baker Heart and Diabetes Institute, Melbourne, VIC, Australia
| | - Ulrich Steinseifer
- Department of Mechanical and Aerospace Engineering, Monash University, Melbourne, VIC, Australia.,Baker Heart and Diabetes Institute, Melbourne, VIC, Australia
| | - Geoff Tansley
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia.,School of Engineering and Built Environment, Griffith University, Southport, QLD, Australia
| | - John F Fraser
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia.,School of Medicine, University of Queensland, Brisbane, QLD, Australia
| |
Collapse
|
17
|
Pauls JP, Roberts LA, Stephens A, Fraser JF, Tansley G, Gregory SD. Improving In vitro Evaluation Capabilities of Cardiac Assist Devices through a Validated Exercise Simulation. ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY. IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY. ANNUAL INTERNATIONAL CONFERENCE 2020; 2019:4901-4904. [PMID: 31946959 DOI: 10.1109/embc.2019.8856936] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
Cardiac assist devices require thorough in vitro evaluation prior to in vivo animal trials, which is often undertaken in mock circulatory loops. To allow for best possible device development, mock circulatory loops need to be able to simulate a variety of patient scenarios. Transition from rest to exercise is one of the most commonly simulated patient scenarios, however, to validate in vitro exercise test beds, baseline data on how the healthy heart and circulatory system responds to exercise is required. Steady state and time response data for heart rate (HR), stroke volume (SV) and cardiac output (CO) was continuously recorded using impedance cardiography in 50 healthy subjects (27 male / 23 female) during exercise on a recumbent exercise ergometer. This data was then used to implement an exercise simulation in a mock circulatory loop and both the steady state and transient results were compared with the mean response of subjects transitioning from rest to 60 W exercise. When transitioning from rest to exercise the time constant (τ) and rise time (tr) for HR, SV and CO were between 10.6-19.3s and 24.7-44.3s respectively for both sexes. No significant differences between the genders were found for τ and tr (p>0.05). Mock circulatory loop results of HR, SV and CO were in good accordance with human data. The present data was used to successfully validate in vitro exercise simulations and may be used to validate in silico numerical simulations of exercise, thus further improving the evaluation capabilities for existing and under development cardiac assist devices.
Collapse
|
18
|
Wu EL, Stevens MC, Nestler F, Pauls JP, Bradley AP, Tansley G, Fraser JF, Gregory SD. A Starling-like total work controller for rotary blood pumps: An in vitro evaluation. Artif Organs 2019; 44:E40-E53. [PMID: 31520408 DOI: 10.1111/aor.13570] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2019] [Revised: 08/24/2019] [Accepted: 09/03/2019] [Indexed: 11/26/2022]
Abstract
Due to improved durability and survival rates, rotary blood pumps (RBPs) are the preferred left ventricular assist device when compared to volume displacement pumps. However, when operated at constant speed, RBPs lack a volume balancing mechanism which may result in left ventricular suction and suboptimal ventricular unloading. Starling-like controllers have previously been developed to balance circulatory volumes; however, they do not consider ventricular workload as a feedback and may have limited sensitivity to adjust RBP workload when ventricular function deteriorates or improves. To address this, we aimed to develop a Starling-like total work controller (SL-TWC) that matched the energy output of a healthy heart by adjusting RBP hydraulic work based on measured left ventricular stroke work and ventricular preload. In a mock circulatory loop, the SL-TWC was evaluated using a HeartWare HVAD in a range of simulated patient conditions. These conditions included changes in systemic hypertension and hypotension, pulmonary hypertension, blood circulatory volume, exercise, and improvement and deterioration of ventricular function by increasing and decreasing ventricular contractility. The SL-TWC was compared to constant speed control where RBP speed was set to restore cardiac output to 5.0 L/min at rest. Left ventricular suction occurred with constant speed control during pulmonary hypertension but was prevented with the SL-TWC. During simulated exercise, the SL-TWC demonstrated reduced LVSW (0.51 J) and greater RBP flow (9.2 L/min) compared to constant speed control (LVSW: 0.74 J and RBP flow: 6.4 L/min). In instances of increased ventricular contractility, the SL-TWC reduced RBP hydraulic work while maintaining cardiac output similar to the rest condition. In comparison, constant speed overworked and increased cardiac output. The SL-TWC balanced circulatory volumes by mimicking the Starling mechanism, while also considering changes in ventricular workload. Compared to constant speed control, the SL-TWC may reduce complications associated with volume imbalances, adapt to changes in ventricular function and improve patient quality of life.
Collapse
Affiliation(s)
- Eric L Wu
- Innovative Cardiovascular Engineering Technology Laboratory (ICETLAB), Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia.,School of Medicine, The University of Queensland, Brisbane, Queensland, Australia
| | - Michael C Stevens
- Graduate School of Biomedical Engineering, University of New South Wales, Sydney, New South Wales, Australia.,Central Clinical School, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia
| | - Frank Nestler
- School of Information Technology and Electrical Engineering, The University of Queensland, Brisbane, Queensland, Australia.,BiVACOR Pty Ltd, Brisbane, Queensland, Australia
| | - Jo P Pauls
- Innovative Cardiovascular Engineering Technology Laboratory (ICETLAB), Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia.,School of Engineering and Built Environment, Griffith University, Gold Coast, Queensland, Australia
| | - Andrew P Bradley
- School of Information Technology and Electrical Engineering, The University of Queensland, Brisbane, Queensland, Australia.,Science and Engineering Faculty, Queensland University of Technology, Brisbane, Queensland, Australia
| | - Geoff Tansley
- Innovative Cardiovascular Engineering Technology Laboratory (ICETLAB), Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia.,School of Engineering and Built Environment, Griffith University, Gold Coast, Queensland, Australia
| | - John F Fraser
- Innovative Cardiovascular Engineering Technology Laboratory (ICETLAB), Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia.,School of Medicine, The University of Queensland, Brisbane, Queensland, Australia
| | - Shaun D Gregory
- Innovative Cardiovascular Engineering Technology Laboratory (ICETLAB), Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia.,School of Medicine, The University of Queensland, Brisbane, Queensland, Australia.,School of Engineering and Built Environment, Griffith University, Gold Coast, Queensland, Australia.,Department of Mechanical and Aerospace Engineering, Monash University, Melbourne, Victoria, Australia.,Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia
| |
Collapse
|
19
|
Stephens A, Gregory S, Tansley G, Busch A, Salamonsen R. In vitro evaluation of an adaptive Starling-like controller for dual rotary ventricular assist devices. Artif Organs 2019; 43:E294-E307. [PMID: 31188476 DOI: 10.1111/aor.13510] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2019] [Revised: 05/19/2019] [Accepted: 05/31/2019] [Indexed: 01/02/2023]
Abstract
Rotary ventricular assist devices (VADs) operated clinically under constant speed control (CSC) cannot respond adequately to changes in patient cardiac demand, resulting in sub-optimal VAD flow regulation. Starling-like control (SLC) of VADs mimics the healthy ventricular flow regulation and automatically adjusts VAD speed to meet varying patient cardiac demand. The use of a fixed control line (CL - the relationship between ventricular preload and VAD flow) limits the flow regulating capability of the controller, especially in the case of exercise. Adaptive SLC (ASLC) overcomes this limitation by allowing the controller to adapt the CL to meet a diverse range of circulatory conditions. This study evaluated ASLC, SLC and CSC in a biventricular supported mock circulation loop under the simulated conditions of exercise, sleep, fluid loading and systemic hypertension. Each controller was evaluated on its ability to remain within predefined limits of VAD flow, preload, and afterload. The ASLC produced superior cardiac output (CO) during exercise (10.1 L/min) compared to SLC (7.3 L/min) and CSC (6.3 L/min). The ASLC produced favourable haemodynamics during sleep, fluid loading and systemic hypertension and could remain within a predefined haemodynamic range in three out of four simulations, suggesting improved haemodynamic performance over SLC and CSC.
Collapse
Affiliation(s)
- Andrew Stephens
- Department of Mechanical and Aerospace Engineering, Monash University, Victoria, Australia.,Cardiorespiratory Engineering and Technology Laboratory, Baker Heart and Diabetes Institute, Victoria, Australia.,Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Queensland, Australia.,School of Engineering and Built Environment, Griffith Sciences, Griffith University, Queensland, Australia
| | - Shaun Gregory
- Department of Mechanical and Aerospace Engineering, Monash University, Victoria, Australia.,Cardiorespiratory Engineering and Technology Laboratory, Baker Heart and Diabetes Institute, Victoria, Australia.,Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Queensland, Australia.,School of Engineering and Built Environment, Griffith Sciences, Griffith University, Queensland, Australia
| | - Geoff Tansley
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Queensland, Australia.,School of Engineering and Built Environment, Griffith Sciences, Griffith University, Queensland, Australia
| | - Andrew Busch
- School of Engineering and Built Environment, Griffith Sciences, Griffith University, Queensland, Australia
| | - Robert Salamonsen
- Department of Epidemiology and Preventive Medicine, Monash University, Victoria, Australia
| |
Collapse
|
20
|
King JM, Bergeron CA, Taylor CE. Finite state machine implementation for left ventricle modeling and control. Biomed Eng Online 2019; 18:10. [PMID: 30700298 PMCID: PMC6354391 DOI: 10.1186/s12938-019-0628-3] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2018] [Accepted: 01/16/2019] [Indexed: 11/24/2022] Open
Abstract
Background Simulation of a left ventricle has become a critical facet of evaluating therapies and operations that interact with cardiac performance. The ability to simulate a wide range of possible conditions, changes in cardiac performance, and production of nuisances at transition points enables evaluation of precision medicine concepts that are designed to function through this spectrum. Ventricle models have historically been based on biomechanical analysis, with model architectures constituted of continuous states and not conducive to deterministic processing. Producing a finite-state machine governance of a left ventricle model would enable a broad range of applications: physiological controller development, experimental left ventricle control, and high throughput simulations of left ventricle function. Methods A method for simulating left ventricular pressure-volume control utilizing a preload, afterload, and contractility sensitive computational model is shown. This approach uses a logic-based conditional finite state machine based on the four pressure-volume phases that describe left ventricular function. This was executed with a physical system hydraulic model using MathWorks’ Simulink® and Stateflow tools. Results The approach developed is capable of simulating changes in preload, afterload, and contractility in time based on a patient’s preload analysis. Six pressure–volume loop simulations are presented to include a base-line, preload change only, afterload change only, contractility change only, a clinical control, and heart failure with normal ejection fraction. All simulations produced an error of less than 1 mmHg and 1 mL of the absolute difference between the desired and simulated pressure and volume set points. The acceptable performance of the fixed-timestep architecture in the finite state machine allows for deployment to deterministic systems, such as experimental systems for validation. Conclusions The proposed approach allows for personalized data, revealed through an individualized clinical pressure–volume analysis, to be simulated in silico. The computational model architecture enables this control structure to be executed on deterministic systems that govern experimental left ventricles. This provides a mock circulatory system with the ability to investigate the pathophysiology for a specific individual by replicating the exact pressure–volume relationship defined by their left ventricular functionality; as well as perform predictive analysis regarding changes in preload, afterload, and contractility in time.
Collapse
Affiliation(s)
- Jacob M King
- Department of Mechanical Engineering, University of Louisiana at Lafayette, 241 E. Lewis St. RM320, Lafayette, LA, 70503, USA
| | - Clint A Bergeron
- Department of Mechanical Engineering, University of Louisiana at Lafayette, 241 E. Lewis St. RM320, Lafayette, LA, 70503, USA
| | - Charles E Taylor
- Department of Mechanical Engineering, University of Louisiana at Lafayette, 241 E. Lewis St. RM320, Lafayette, LA, 70503, USA.
| |
Collapse
|
21
|
Eric Wu L, Tansley G, John Fraser F, Shaun Gregory D. In-Vitro Evaluation of Cardiac Energetics and Coronary Flow with Volume Displacement and Rotary Blood Pumps. ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY. IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY. ANNUAL INTERNATIONAL CONFERENCE 2018; 2018:5277-5281. [PMID: 30441528 DOI: 10.1109/embc.2018.8513158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Bridge to recovery with left ventricular assist device (LVAD) support has been more prominent with volume displacement pumps (VDPs) than with rotary blood pumps (RBPs), which may be due to VDPs providing greater ventricular unloading and coronary artery flow. To compare ventricular unloading and coronary flow of VDPs and RBPs in a repeatable environment, a physiologic coronary circulation was added to a pre-existing mock circulatory loop. In this study, a physiologic coronary circulation, mimicking a healthy or diseased auto-regulatory response was implemented in a mock circulatory loop. Using the mock circulation loop, a VDP with original (Björk-Shiley) and then replacement (jellyfish) valves was operated in clinically recommended modes and compared to full and partial assist RBP operating at constant speed and rapid speed modulated modes. The Björk-Shiley VDP resulted in increased pressure-volume area, which resulted in greater coronary artery flow when compared to the improved jellyfish valves. Full assist RBP support reduced left ventricular stroke work, pressure-volume area and coronary flow compared to partial assist, whilst the effect of speed modulation modes was not as significant. Of all LVAD operating modes, the counter-pulsed VDP with jellyfish valves demonstrated the greatest reduction in pressure-volume area and improved coronary flow. This study provides a basis for further investigation into RBP speed modulation profiles to match the improved haemodynamic performance of VDPs.
Collapse
|
22
|
Stephens AF, Gregory SD, Salamonsen RF. The Importance of Venous Return in Starling-Like Control of Rotary Ventricular Assist Devices. Artif Organs 2018; 43:E16-E27. [PMID: 30094842 DOI: 10.1111/aor.13342] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2018] [Revised: 07/05/2018] [Accepted: 08/01/2018] [Indexed: 12/20/2022]
Abstract
Rotary ventricular assist devices (VADs) are less sensitive to preload than the healthy heart, resulting in inadequate flow regulation in response to changes in patient cardiac demand. Starling-like physiological controllers (SLCs) have been developed to automatically regulate VAD flow based on ventricular preload. An SLC consists of a cardiac response curve (CRC) which imposes a nonlinear relationship between VAD flow and ventricular preload, and a venous return line (VRL) which determines the return path of the controller. This study investigates the importance of a physiological VRL in SLC of dual rotary blood pumps for biventricular support. Two experiments were conducted on a physical mock circulation loop (MCL); the first compared an SLC with an angled physiological VRL (SLC-P) against an SLC with a vertical VRL (SLC-V). The second experiment quantified the benefit of a dynamic VRL, represented by a series of specific VRLs, which could adapt to different circulatory states including changes in pulmonary (PVR) and systemic (SVR) vascular resistance versus a fixed physiological VRL which was calculated at rest. In both sets of experiments, the transient controller responses were evaluated through reductions in preload caused by the removal of fluid from the MCL. The SLC-P produced no overshoot or oscillations following step changes in preload, whereas SLC-V produced 0.4 L/min (12.5%) overshoot for both left and right VADs. Additionally, the SLC-V had increased settling time and reduced controller stability as evidenced by transient controller oscillations. The transient results comparing the specific and standard VRLs demonstrated that specific VRL rise times were improved by between 1.2 and 4.7 s ( x ¯ = 3.05 s), while specific VRL settling times were improved by between 2.8 and 16.1 seconds ( x ¯ = 8.38 s) over the standard VRL. This suggests only a minor improvement in controller response time from a dynamic VRL compared to the fixed VRL. These results indicate that the use of a fixed physiologically representative VRL is adequate over a wide variety of physiological conditions.
Collapse
Affiliation(s)
- Andrew F Stephens
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia.,School of Engineering and Built Environment, Griffith University, QLD, Australia
| | - Shaun D Gregory
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia.,School of Engineering and Built Environment, Griffith University, QLD, Australia.,School of Mechanical and Aerospace Engineering, Monash University, VIC, Australia
| | - Robert F Salamonsen
- Department of Epidemiology and Preventive Medicine, Monash University, VIC, Australia.,Intensive Care Unit, Alfred Hospital, Prahran, VIC, Australia
| |
Collapse
|
23
|
Graefe R, Beyel C, Henseler A, Körfer R, Steinseifer U, Tenderich G. The Effect of LVAD Pressure Sensitivity on the Assisted Circulation Under Consideration of a Mitral Insufficiency: An In Vitro Study. Artif Organs 2018; 42:E304-E314. [DOI: 10.1111/aor.13279] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2017] [Revised: 03/27/2018] [Accepted: 04/16/2018] [Indexed: 01/28/2023]
Affiliation(s)
| | | | | | - Reiner Körfer
- ReinVAD GmbH; Aachen Germany
- Department for the Surgical Therapy of End-stage Heart Failure and Mechanical Circulatory Support; Heart- and Vascular Center Duisburg; Duisburg Germany
| | - Ulrich Steinseifer
- Department of Cardiovascular Engineering; Institute of Applied Medical Engineering, Helmholtz Institute, RWTH Aachen University; Aachen Germany
| | - Gero Tenderich
- Department for the Surgical Therapy of End-stage Heart Failure and Mechanical Circulatory Support; Heart- and Vascular Center Duisburg; Duisburg Germany
| |
Collapse
|
24
|
King JM, Bergeron CA, Taylor CE. Development of an adaptive pulmonary simulator for in vitro analysis of patient populations and patient-specific data. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE 2018; 161:93-102. [PMID: 29852971 DOI: 10.1016/j.cmpb.2018.04.007] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/22/2017] [Revised: 03/14/2018] [Accepted: 04/09/2018] [Indexed: 06/08/2023]
Abstract
BACKGROUND AND OBJECTIVE Patient-specific modeling (PSM) is gaining more attention from researchers due to its ability to potentially improve diagnostic capabilities, guide the design of intervention procedures, and optimize clinical management by predicting the outcome of a particular treatment and/or surgical intervention. Due to the hemodynamic diversity of specific patients, an adaptive pulmonary simulator (PS) would be essential for analyzing the possible impact of external factors on the safety, performance, and reliability of a cardiac assist device within a mock circulatory system (MCS). In order to accurately and precisely replicate the conditions within the pulmonary system, a PS should not only account for the ability of the pulmonary system to supply blood flow at specific pressures, but similarly consider systemic outflow dynamics. This would provide an accurate pressure and flow rate return supply back into the left ventricular section of the MCS (i.e. the initial conditions of the left heart). METHODS Employing an embedded Windkessel model, a control system model was developed utilizing MathWorks' Simulink® Simscape™. Following a verification and validation (V&V) analysis approach, a PI-controlled closed-loop hydraulic system was developed using Simscape™. This physical system modeling tool was used to (1) develop and control the in silico system during verification studies and (2) simulate pulmonary performance for validation of this control architecture. RESULTS The pulmonary Windkessel model developed is capable of generating the left atrial pressure (LAP) waveform from given pulmonary factors, aortic conditions, and systemic variables. Verification of the adaptive PS's performance and validation of this control architecture support this modeling methodology as an effective means of reproducing pulmonary pressure waveforms and systemic outflow conditions, unique to a particular patient. Adult and geriatric with and without Heart Failure and a Normal Ejection Fraction (HFNEF) are presented. CONCLUSIONS The adaptability of this modelling approach allows for the simulation of pulmonary conditions without the limitations of a dedicated hardware platform for use in in vitro investigations.
Collapse
Affiliation(s)
- Jacob M King
- Cajun Artificial Heart Laboratory, Mechanical Engineering Department, University of Louisiana at Lafayette, 241 E. Lewis St. RM320, Lafayette, LA 70503, United States
| | - Clint A Bergeron
- Cajun Artificial Heart Laboratory, Mechanical Engineering Department, University of Louisiana at Lafayette, 241 E. Lewis St. RM320, Lafayette, LA 70503, United States
| | - Charles E Taylor
- Cajun Artificial Heart Laboratory, Mechanical Engineering Department, University of Louisiana at Lafayette, 241 E. Lewis St. RM320, Lafayette, LA 70503, United States.
| |
Collapse
|
25
|
Feldmann C, Deniz E, Stomps A, Knigge S, Chatterjee A, Wendl R, Hanke JS, Dogan G, Napp LC, Glasmacher B, Haverich A, Schmitto JD. An acoustic method for systematic ventricular assist device thrombus evaluation with a novel artificial thrombus model. J Thorac Dis 2018; 10:S1711-S1719. [PMID: 30034843 PMCID: PMC6035965 DOI: 10.21037/jtd.2018.04.11] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2018] [Accepted: 03/27/2018] [Indexed: 11/06/2022]
Abstract
BACKGROUND Pump thrombosis (PT) is still one of the major adverse events in patients supported with left ventricular assist devices. Nowadays, thrombus detection relies on clinical parameters like reoccurring heart failure symptoms, on changes in pump power consumption, and on laboratory parameters such as increased LDH and hemolysis. Once detected PT is most often persistent and refractory to medical therapy. We therefore designed a novel, non-invasive acoustic method for early pump thrombus detection in an in vitro artificial thrombus model. METHODS The study was performed in vitro using a mock circulation loop, artificial blood (water-glycerin) and artificial thrombus material (silicon) allowing for repeatable and defined testing. Tested ventricular assist device (VAD) type was HVAD (Medtronic). Three different thrombus locations were evaluated: on the tilted pad of the rotor, in the primary flow path, and in the secondary flow path beneath the rotor. After evaluating baseline parameters (no thrombus, n=20 for each pump), the influence of thrombi of seven different masses (no thrombus, 0.5-5.0 mg) on pump power consumption and acoustic emission of four HVAD devices was investigated via a microphone system (Sennheiser) and subsequent frequency spectrum analysis (n=12). The acoustic analysis algorithm included the number of frequency peaks recorded. RESULTS Measurements with thrombi on the tilted pad showed an increased number of frequency peaks with all thrombus sizes compared to baseline measurements without any thrombus (baseline: 32.7±7.4; 0.5 mg: 45.3±10.4 up to 5 mg: 80.4±5.5). Power consumption was relevantly elevated in 5mg thrombus measurement only (6.3±1.29 W compared to 4.9±0.14 W at baseline). Measurements with thrombi in the primary and secondary showed no relevant alteration in power consumption and frequency peak count. CONCLUSIONS We present an acoustic method that detects pump thrombi located on the tilted pad of the HVAD rotor requiring ten times less mass compared to thrombi detected by power consumption alterations used in current detection algorithms. Assuming that pump thrombi are growing over several days, the presented method may detect PT much earlier thereby increasing efficacy of medical therapy and helping to avoid pump exchange.
Collapse
Affiliation(s)
- Christina Feldmann
- Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
| | - Ezin Deniz
- Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
| | - Alexander Stomps
- Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
- Institute for Multiphase Processes, Leibniz Universität Hannover, Hannover, Germany
| | - Sara Knigge
- Institute for Multiphase Processes, Leibniz Universität Hannover, Hannover, Germany
| | - Anamika Chatterjee
- Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
| | - Regina Wendl
- Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
| | - Jasmin S. Hanke
- Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
| | - Günes Dogan
- Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
| | - L. Christian Napp
- Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany
| | - Birgit Glasmacher
- Institute for Multiphase Processes, Leibniz Universität Hannover, Hannover, Germany
| | - Axel Haverich
- Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
| | - Jan D. Schmitto
- Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
| |
Collapse
|
26
|
Ng BC, Kleinheyer M, Smith PA, Timms D, Cohn WE, Lim E. Pulsatile operation of a continuous-flow right ventricular assist device (RVAD) to improve vascular pulsatility. PLoS One 2018; 13:e0195975. [PMID: 29677212 PMCID: PMC5909905 DOI: 10.1371/journal.pone.0195975] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2017] [Accepted: 04/03/2018] [Indexed: 11/18/2022] Open
Abstract
Despite the widespread acceptance of rotary blood pump (RBP) in clinical use over the past decades, the diminished flow pulsatility generated by a fixed speed RBP has been regarded as a potential factor that may lead to adverse events such as vasculature stiffening and hemorrhagic strokes. In this study, we investigate the feasibility of generating physiological pulse pressure in the pulmonary circulation by modulating the speed of a right ventricular assist device (RVAD) in a mock circulation loop. A rectangular pulse profile with predetermined pulse width has been implemented as the pump speed pattern with two different phase shifts (0% and 50%) with respect to the ventricular contraction. In addition, the performance of the speed modulation strategy has been assessed under different cardiovascular states, including variation in ventricular contractility and pulmonary arterial compliance. Our results indicated that the proposed pulse profile with optimised parameters (Apulse = 10000 rpm and ωmin = 3000 rpm) was able to generate pulmonary arterial pulse pressure within the physiological range (9–15 mmHg) while avoiding undesirable pump backflow under both co- and counter-pulsation modes. As compared to co-pulsation, stroke work was reduced by over 44% under counter-pulsation, suggesting that mechanical workload of the right ventricle can be efficiently mitigated through counter-pulsing the pump speed. Furthermore, our results showed that improved ventricular contractility could potentially lead to higher risk of ventricular suction and pump backflow, while stiffening of the pulmonary artery resulted in increased pulse pressure. In conclusion, the proposed speed modulation strategy produces pulsatile hemodynamics, which is more physiologic than continuous blood flow. The findings also provide valuable insight into the interaction between RVAD speed modulation and the pulmonary circulation under various cardiovascular states.
Collapse
Affiliation(s)
- Boon C. Ng
- Department of Biomedical Engineering, University of Malaya, Kuala Lumpur, Malaysia
- Texas Heart Institute, Houston, Texas, United States of America
| | | | - Peter A. Smith
- Texas Heart Institute, Houston, Texas, United States of America
| | - Daniel Timms
- BiVACOR, Inc, Houston, Texas, United States of America
| | - William E. Cohn
- Texas Heart Institute, Houston, Texas, United States of America
| | - Einly Lim
- Department of Biomedical Engineering, University of Malaya, Kuala Lumpur, Malaysia
- * E-mail:
| |
Collapse
|
27
|
Smith PA, De-Sciscio P, Sampaio LC, Cohn WE, McMahon RA. Replication of pressure-volume loop with controllable ESPVR and EDPVR curves on a personalized mock circulatory loop based on elastance function. ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY. IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY. ANNUAL INTERNATIONAL CONFERENCE 2017; 2017:1282-1286. [PMID: 29060110 DOI: 10.1109/embc.2017.8037066] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
In the development of a left ventricular assist device (LVAD), it is important to evaluate the LVAD's hemodynamic effect on the compromised left ventricle (LV) before surgical implantation. The mock circulatory loop (MCL) is widely accepted as an in vitro test platform to evaluate LVADs across a wide range of operational conditions as a way to examine how the device and the cardiovascular system interact. Unfortunately, most MCLs represent an oversimplified model of cardiac function, with disease states simulated through generalized changes in heart rate and stroke volume. Because heart failure (HF) severity varies substantially among patients, an MCL is needed that can mimic the pressure-volume loop of an individual patient. In this work, two numerical elastance models, derived from a specific pressure volume loop template, were used to control the LV simulator of the MCL to simulate different degrees of HF. The numerical elastance model was then scaled to change the slopes of the end-systolic (ESPVR) and end-diastolic (EDPVR) pressure volume relationship curves to simulate systolic and diastolic dysfunction. The resulting experimental pressure volume loops are consistent with theoretical loops, demonstrating the feasibility of creating an MCL that can be customized for the patient.
Collapse
|
28
|
Platts DG, Bartnikowski N, Gregory SD, Scalia GM, Fraser JF. Contrast Microsphere Destruction by a Continuous Flow Ventricular Assist Device: An In Vitro Evaluation Using a Mock Circulation Loop. BIOMED RESEARCH INTERNATIONAL 2017; 2017:4907898. [PMID: 28884121 PMCID: PMC5572588 DOI: 10.1155/2017/4907898] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/06/2017] [Accepted: 06/22/2017] [Indexed: 01/11/2023]
Abstract
OBJECTIVES Transthoracic echocardiography (TTE) is fundamental in managing patients supported with ventricular assist devices (VAD). However imaging can be difficult in these patients. Contrast improves image quality but they are hydrodynamically fragile agents. The aim was to assess contrast concentration following passage through a VAD utilising a mock circulation loop (MCL). METHODS Heartware continuous flow (CF) VAD was incorporated into a MCL. Definity® contrast was infused into the MCL with imaging before and after CF-VAD. 5 mm2 regions of interest were used to obtain signal intensity (decibels), as a surrogate of contrast concentration. RESULTS Four pump speeds revealed significant reduction in contrast signal intensity after CF-VAD compared to before CF-VAD (all p < 0.0001). Combined pre- and postpump data at all speeds showed a 22.2% absolute reduction in contrast signal intensity across the CF-VAD (14.8 ± 0.8 dB prepump versus 11.6 ± 1.4 dB postpump; p < 0.0001). Mean signal intensity reduction at each speed showed an inverse relationship between speed and relative reduction in signal intensity. CONCLUSION Contrast microsphere transit through a CF-VAD within a MCL resulted in significant reduction in signal intensity, consistent with destruction within the pump. This was evident at all CF-VAD pump speeds but relative signal drop was inversely proportional to pump speed.
Collapse
Affiliation(s)
- David G. Platts
- Department of Echocardiography, The Prince Charles Hospital, Brisbane, QLD, Australia
- School of Medicine, University of Queensland, Brisbane, QLD, Australia
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia
| | - Nicole Bartnikowski
- School of Chemistry, Physics and Mechanical Engineering, Queensland University of Technology, Brisbane, QLD, Australia
| | - Shaun D. Gregory
- School of Medicine, University of Queensland, Brisbane, QLD, Australia
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia
- School of Engineering, Griffith University, Brisbane, QLD, Australia
| | - Gregory M. Scalia
- Department of Echocardiography, The Prince Charles Hospital, Brisbane, QLD, Australia
- School of Medicine, University of Queensland, Brisbane, QLD, Australia
- Heart Care Partners, Wesley Hospital, Brisbane, QLD, Australia
| | - John F. Fraser
- School of Medicine, University of Queensland, Brisbane, QLD, Australia
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia
- Adult Intensive Care Service, The Prince Charles Hospital, Brisbane, QLD, Australia
| |
Collapse
|
29
|
Stephens AF, Stevens MC, Gregory SD, Kleinheyer M, Salamonsen RF. In Vitro Evaluation of an Immediate Response Starling-Like Controller for Dual Rotary Blood Pumps. Artif Organs 2017; 41:911-922. [PMID: 28741664 DOI: 10.1111/aor.12962] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2016] [Revised: 03/26/2017] [Accepted: 04/12/2017] [Indexed: 11/30/2022]
Abstract
Rotary ventricular assist devices (VADs) are used to provide mechanical circulatory support. However, their lack of preload sensitivity in constant speed control mode (CSC) may result in ventricular suction or venous congestion. This is particularly true of biventricular support, where the native flow-balancing Starling response of both ventricles is diminished. It is possible to model the Starling response of the ventricles using cardiac output and venous return curves. With this model, we can create a Starling-like physiological controller (SLC) for VADs which can automatically balance cardiac output in the presence of perturbations to the circulation. The comparison between CSC and SLC of dual HeartWare HVADs using a mock circulation loop to simulate biventricular heart failure has been reported. Four changes in cardiovascular state were simulated to test the controller, including a 700 mL reduction in circulating fluid volume, a total loss of left and right ventricular contractility, reduction in systemic vascular resistance ( SVR) from 1300 to 600 dyne s/cm5, and an elevation in pulmonary vascular resistance ( PVR) from 100 to 300 dyne s/cm5. SLC maintained the left and right ventricular volumes between 69-214 mL and 29-182 mL, respectively, for all tests, preventing ventricular suction (ventricular volume = 0 mL) and venous congestion (atrial pressures > 20 mm Hg). Cardiac output was maintained at sufficient levels by the SLC, with systemic and pulmonary flow rates maintained above 3.14 L/min for all tests. With the CSC, left ventricular suction occurred during reductions in SVR, elevations in PVR, and reduction in circulating fluid simulations. These results demonstrate a need for a physiological control system and provide adequate in vitro validation of the immediate response of a SLC for biventricular support.
Collapse
Affiliation(s)
- Andrew F Stephens
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia.,School of Engineering, Griffith University, QLD, Australia
| | - Michael C Stevens
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia.,Graduate School of Biomedical Engineering, University of New South Wales, NSW, Australia.,Sydney Medical School, University of Sydney, NSW, Australia
| | - Shaun D Gregory
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia.,School of Engineering, Griffith University, QLD, Australia.,School of Medicine, University of Queensland, QLD, Australia
| | - Matthias Kleinheyer
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia.,School of Engineering, Griffith University, QLD, Australia
| | - Robert F Salamonsen
- Department of Epidemiology and Preventive Medicine, Monash University, VIC, Australia.,Intensive Care Unit, Alfred Hospital, Prahran, VIC, Australia
| |
Collapse
|
30
|
Wu EL, Nestler F, Kleinheyer M, Stevens MC, Pauls JP, Fraser JF, Gregory SD. Pulmonary Valve Opening With Two Rotary Left Ventricular Assist Devices for Biventricular Support. Artif Organs 2017; 42:31-40. [PMID: 28741841 DOI: 10.1111/aor.12967] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2016] [Revised: 03/24/2017] [Accepted: 04/25/2017] [Indexed: 11/26/2022]
Abstract
Right ventricular failure is a common complication associated with rotary left ventricular assist device (LVAD) support. Currently, there is no clinically approved long-term rotary right ventricular assist device (RVAD). Instead, clinicians have implanted a second rotary LVAD as RVAD in biventricular support. To prevent pulmonary hypertension, the RVAD must be operated by either reducing pump speed or banding the outflow graft. These modes differ in hydraulic performance, which may affect the pulmonary valve opening (PVO) and subsequently cause fusion, valvular insufficiency, and thrombus formation. This study aimed to compare PVO with the RVAD operated at reduced speed or with a banded outflow graft. Baseline conditions of systemic normal, hypo, and hypertension with severe biventricular failure were simulated in a mock circulation loop. Biventricular support was provided with two rotary VentrAssist LVADs with cardiac output restored to 5 L/min in banded outflow and reduced speed conditions, and systemic and pulmonary vascular resistances (PVR) were manipulated to determine the range of conditions that allowed PVO without causing left ventricular suction. Finally, RVAD sine wave speed modulation (±550 rpm) strategies (co- and counter-pulsation) were implemented to observe the effect on PVO. For each condition, outflow banding had higher PVR (97 ± 20 dyne/s/cm5 higher) for when the pulmonary valve closed compared to reduced speed. In addition, counter-pulsation demonstrated greater PVO than co-pulsation and constant speed. For the purpose of reducing the risks of pulmonary valve insufficiency, fusion, and thrombotic event, this study recommends a RVAD with a steeper H-Q gradient by banding and further exploration of RVAD speed modulation.
Collapse
Affiliation(s)
- Eric L Wu
- Innovative Cardiovascular Engineering and Technology Laboratory (ICETLAB), Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia.,School of Medicine, The University of Queensland, Brisbane, Australia
| | - Frank Nestler
- School of Information Technology and Electrical Engineering, The University of Queensland, Brisbane, Australia
| | - Matthias Kleinheyer
- Innovative Cardiovascular Engineering and Technology Laboratory (ICETLAB), Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia.,School of Engineering, Griffith University, Southport, Australia
| | - Michael C Stevens
- Graduate School of Biomedical Engineering, University of New South Wales, Sydney, Australia.,Central Clinical School, Sydney Medical School, University of Sydney, Sydney, Australia
| | - Jo P Pauls
- Innovative Cardiovascular Engineering and Technology Laboratory (ICETLAB), Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia.,School of Engineering, Griffith University, Southport, Australia
| | - John F Fraser
- Innovative Cardiovascular Engineering and Technology Laboratory (ICETLAB), Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia.,School of Medicine, The University of Queensland, Brisbane, Australia
| | - Shaun D Gregory
- Innovative Cardiovascular Engineering and Technology Laboratory (ICETLAB), Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia.,School of Medicine, The University of Queensland, Brisbane, Australia.,School of Engineering, Griffith University, Southport, Australia
| |
Collapse
|
31
|
Telyshev DV, Pugovkin AA, Selishchev SV. A Mock Circulatory System for Testing Pediatric Rotary Blood Pumps. BIOMEDICAL ENGINEERING-MEDITSINSKAYA TEKNIKA 2017. [DOI: 10.1007/s10527-017-9689-4] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
32
|
Crosby JR, DeCook KJ, Tran PL, Betterton E, Smith RG, Larson DF, Khalpey ZI, Burkhof D, Slepian MJ. A Physical Heart Failure Simulation System Utilizing the Total Artificial Heart and Modified Donovan Mock Circulation. Artif Organs 2017; 41:E52-E65. [PMID: 27935084 PMCID: PMC5466504 DOI: 10.1111/aor.12808] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2016] [Revised: 06/21/2016] [Accepted: 06/30/2016] [Indexed: 01/11/2023]
Abstract
With the growth and diversity of mechanical circulatory support (MCS) systems entering clinical use, a need exists for a robust mock circulation system capable of reliably emulating and reproducing physiologic as well as pathophysiologic states for use in MCS training and inter-device comparison. We report on the development of such a platform utilizing the SynCardia Total Artificial Heart and a modified Donovan Mock Circulation System, capable of being driven at normal and reduced output. With this platform, clinically relevant heart failure hemodynamics could be reliably reproduced as evidenced by elevated left atrial pressure (+112%), reduced aortic flow (-12.6%), blunted Starling-like behavior, and increased afterload sensitivity when compared with normal function. Similarly, pressure-volume relationships demonstrated enhanced sensitivity to afterload and decreased Starling-like behavior in the heart failure model. Lastly, the platform was configured to allow the easy addition of a left ventricular assist device (HeartMate II at 9600 RPM), which upon insertion resulted in improvement of hemodynamics. The present configuration has the potential to serve as a viable system for training and research, aimed at fostering safe and effective MCS device use.
Collapse
Affiliation(s)
- Jessica R. Crosby
- Biomedical Engineering GIDP, University of Arizona, Tucson, Arizona 85724
| | - Katrina J. DeCook
- Biomedical Engineering GIDP, University of Arizona, Tucson, Arizona 85724
| | - Phat L. Tran
- Biomedical Engineering GIDP, University of Arizona, Tucson, Arizona 85724
- Department of Medicine, Sarver Heart Center, University of Arizona, Tucson, Arizona 85724 43Artificial Heart Department, Banner University Medical Center, University of Arizona, Tucson, Arizona 85724
| | | | - Richard G. Smith
- Biomedical Engineering GIDP, University of Arizona, Tucson, Arizona 85724
- Department of Medicine, Sarver Heart Center, University of Arizona, Tucson, Arizona 85724 43Artificial Heart Department, Banner University Medical Center, University of Arizona, Tucson, Arizona 85724
- Department of Surgery, University of Arizona, Tucson, AZ 85724
| | | | - Zain I. Khalpey
- Department of Surgery, University of Arizona, Tucson, AZ 85724
| | | | - Marvin J. Slepian
- Biomedical Engineering GIDP, University of Arizona, Tucson, Arizona 85724
- Department of Biomedical Engineering, University of Arizona, Tucson, Arizona 85724
- Department of Medicine, Sarver Heart Center, University of Arizona, Tucson, Arizona 85724 43Artificial Heart Department, Banner University Medical Center, University of Arizona, Tucson, Arizona 85724
| |
Collapse
|
33
|
Jansen-Park SH, Hsu PL, Müller I, Steinseifer U, Abel D, Autschbach R, Rossaint R, Schmitz-Rode T. A mock heart engineered with helical aramid fibers for in vitro cardiovascular device testing. BIOMED ENG-BIOMED TE 2017; 62:139-148. [PMID: 28375841 DOI: 10.1515/bmt-2016-0106] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2016] [Accepted: 03/01/2017] [Indexed: 11/15/2022]
Abstract
Mock heart circulation loops (MHCLs) serve as in-vitro platforms to investigate the physiological interaction between circulatory systems and cardiovascular devices. A mock heart (MH) engineered with silicone walls and helical aramid fibers, to mimic the complex contraction of a natural heart, has been developed to advance the MHCL previously developed in our group. A mock aorta with an anatomical shape enables the evaluation of a cannulation method for ventricular assist devices (VADs) and investigation of the usage of clinical measurement systems like pressure-volume catheters. Ventricle and aorta molds were produced based on MRI data and cast with silicone. Aramid fibers were layered in the silicone ventricle to reproduce ventricle torsion. A rotating hollow shaft was connected to the apex enabling the rotation of the MH and the connection of a VAD. Silicone wall thickness, aramid fiber angle and fiber pitch were varied to generate different MH models. All MH models were placed in a tank filled with variable amounts of water and air simulating the compliance. In this work, physiological ventricular torsion angles (15°-26°) and physiological pressure-volume loops were achieved. This MHCL can serve as a comprehensive testing platform for cardiovascular devices, such as artificial heart valves and cannulation of VADs.
Collapse
Affiliation(s)
| | - Po-Lin Hsu
- Artificial Organ Technology Laboratory, Biomufacturing Centre, School of Mechanical and Electric Engineering, Soochow University, Jiangsu
| | - Indra Müller
- Institute of Applied Medical Engineering, RWTH Aachen University, Aachen
| | - Ulrich Steinseifer
- Institute of Applied Medical Engineering, RWTH Aachen University, Aachen
| | - Dirk Abel
- Institute of Automatic Control, RWTH Aachen University, Aachen
| | - Rüdiger Autschbach
- Department of Cardiothoracic and Vascular Surgery, University Hospital Aachen, Aachen
| | - Rolf Rossaint
- Department of Anesthesiology, University Hospital Aachen, Aachen
| | | |
Collapse
|
34
|
Smith PA, Timms DL, McMahon RA. Hemodynamic effects of synchronizing an intra-aortic VAD in reverse-rotation control with left ventricle: a mock loop study. ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY. IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY. ANNUAL INTERNATIONAL CONFERENCE 2017; 2016:4300-4304. [PMID: 28269231 DOI: 10.1109/embc.2016.7591678] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
The IntraVAD is an intra-aortic left ventricular assist device (LVAD) to be located in the ascending aorta. In order to enhance unloading and promote coronary flow for the left ventricle (LV), an operating mechanism, reverse-rotation control (RRc) mode, has been developed for the IntraVAD and tested in vitro in a mock circulation loop (MCL). The RRc mode consists of forward rotation (FR) and reverse rotation (RR). The synchronization between the IntraVAD and the LV was studied to offload the ventricle more effectively and to improve myocardial perfusion. The percentage time length of the FR period in the cardiac cycle (Tlf) and time offset between the central-lines of the FR period and the LV systole (Toc) are two parameters of the RRc mode that were varied to adjust the synchronization between the IntraVAD and the LV. The ejection fraction (EF), coronary perfusion pressure (CPP), and arterial pulsatility index (API) were measured at different Tlf and Toc values. These hemodynamic results closely correlated to the LV unloading, coronary perfusion, and peripheral arterial pulsatility. The EF, CPP and API were fed into a weighted normalized scalar (WNS) which was implemented to comprehensively evaluate the hemodynamic influence. The WNS result shows that the overall hemodynamic response is more sensitive to the changes in Toc value than Tlf value. The result shows a significant reduction in LV afterload by starting the FR before LV contraction, then switching to RR at the onset of ventricular dilation. The optimal phase shift of -π/5 was found to precede LV contraction, indicating that changes in LV afterload are more sensitive to the phase shift at the start of the ventricular systole than at the end. Thus, a phase advance between intra-aortic pumps and the LV is critical to unload the ventricle and promote myocardial recovery.
Collapse
|
35
|
McKenzie SC, Dunster K, Chan W, Brown MR, Platts DG, Javorsky G, Anstey C, Gregory SD. Reliability of thermodilution derived cardiac output with different operator characteristics. J Clin Monit Comput 2017; 32:227-234. [PMID: 28281192 DOI: 10.1007/s10877-017-0010-6] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2016] [Accepted: 02/25/2017] [Indexed: 11/27/2022]
Abstract
Cardiac output (CO) is commonly measured using the thermodilution technique at the time of right heart catheterisation (RHC). However inter-operator variability, and the operator characteristics which may influence that, has not been quantified. Therefore, this study aimed to assess inter-operator variability with the thermodilution technique using a mock circulation loop (MCL) with calibrated flow sensors. Participants were blinded and asked to determine 4 levels of CO using the thermodilution technique, which was compared with the MCL calibrated flow sensors. The MCL was used to randomly generate CO between 3.0 and 7.0 L/min through changes in heart rate, contractility and vascular resistance with a RHC inserted through the MCL pulmonary artery. Participant characteristics including gender, specialty, age, height, weight, body-mass index, grip strength and RHC experience were recorded and compared to determine their relationship with CO measurement accuracy. In total, there were 15 participants, made up of consultant cardiologists (6), advanced trainees in cardiology (5) and intensive care consultants (4). The majority (9) had performed 26-100 previous RHCs, while 4 had performed more than 100 RHCs. Compared to the MCL-measured CO, participants overestimated CO using the thermodilution technique with a mean difference of +0.75 ± 0.71 L/min. The overall r2 value for actual vs measured CO was 0.85. The difference between MCL and thermodilution derived CO declined significantly with increasing RHC experience (P < 0.001), increasing body mass index (P < 0.001) and decreasing grip strength (P = 0.033). This study demonstrated that the thermodilution technique is a reasonable method to determine CO, and that operator experience was the only participant characteristic related to CO measurement accuracy. Our results suggest that adequate exposure to, and training in, the thermodilution technique is required for clinicians who perform RHC.
Collapse
Affiliation(s)
- Scott C McKenzie
- Faculty of Health Sciences, School of Medicine, The University of Queensland, Brisbane, QLD, Australia.,The Prince Charles Hospital, Chermside, QLD, Australia
| | - Kimble Dunster
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia
| | - Wandy Chan
- Faculty of Health Sciences, School of Medicine, The University of Queensland, Brisbane, QLD, Australia.,The Prince Charles Hospital, Chermside, QLD, Australia
| | - Martin R Brown
- Faculty of Health Sciences, School of Medicine, The University of Queensland, Brisbane, QLD, Australia.,The Prince Charles Hospital, Chermside, QLD, Australia
| | - David G Platts
- Faculty of Health Sciences, School of Medicine, The University of Queensland, Brisbane, QLD, Australia.,The Prince Charles Hospital, Chermside, QLD, Australia.,Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia
| | | | - Chris Anstey
- Faculty of Health Sciences, School of Medicine, The University of Queensland, Brisbane, QLD, Australia.,Nambour General Hospital, Nambour, QLD, Australia
| | - Shaun D Gregory
- Faculty of Health Sciences, School of Medicine, The University of Queensland, Brisbane, QLD, Australia. .,Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia. .,School of Engineering, Griffith University, Brisbane, Australia.
| |
Collapse
|
36
|
Mansouri M, Gregory SD, Salamonsen RF, Lovell NH, Stevens MC, Pauls JP, Akmeliawati R, Lim E. Preload-based Starling-like control of rotary blood pumps: An in-vitro evaluation. PLoS One 2017; 12:e0172393. [PMID: 28212401 PMCID: PMC5315328 DOI: 10.1371/journal.pone.0172393] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2016] [Accepted: 01/19/2017] [Indexed: 11/18/2022] Open
Abstract
Due to a shortage of donor hearts, rotary left ventricular assist devices (LVADs) are used to provide mechanical circulatory support. To address the preload insensitivity of the constant speed controller (CSC) used in conventional LVADs, we developed a preload-based Starling-like controller (SLC). The SLC emulates the Starling law of the heart to maintain mean pump flow ( QP¯) with respect to mean left ventricular end diastolic pressure (PLVEDm) as the feedback signal. The SLC and CSC were compared using a mock circulation loop to assess their capacity to increase cardiac output during mild exercise while avoiding ventricular suction (marked by a negative PLVEDm) and maintaining circulatory stability during blood loss and severe reductions in left ventricular contractility (LVC). The root mean squared hemodynamic deviation (RMSHD) metric was used to assess the clinical acceptability of each controller based on pre-defined hemodynamic limits. We also compared the in-silico results from our previously published paper with our in-vitro outcomes. In the exercise simulation, the SLC increased QP¯ by 37%, compared to only 17% with the CSC. During blood loss, the SLC maintained a better safety margin against left ventricular suction with PLVEDm of 2.7 mmHg compared to -0.1 mmHg for CSC. A transition to reduced LVC resulted in decreased mean arterial pressure (MAP) and QP¯ with CSC, whilst the SLC maintained MAP and QP¯. The results were associated with a much lower RMSHD value with SLC (70.3%) compared to CSC (225.5%), demonstrating improved capacity of the SLC to compensate for the varying cardiac demand during profound circulatory changes. In-vitro and in-silico results demonstrated similar trends to the simulated changes in patient state however the magnitude of hemodynamic changes were different, thus justifying the progression to in-vitro evaluation.
Collapse
Affiliation(s)
- Mahdi Mansouri
- Department of Biomedical Engineering, University of Malaya, Kuala Lumpur, Malaysia
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, the Prince Charles Hospital, Brisbane, Queensland, Australia
| | - Shaun D. Gregory
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, the Prince Charles Hospital, Brisbane, Queensland, Australia
- School of Medicine, University of Queensland, Brisbane, Queensland, Australia
- School of Engineering, Griffith University, Brisbane, Queensland, Australia
| | - Robert F. Salamonsen
- Department of Intensive Care, Alfred Hospital, Prahran, Victoria, Australia
- Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
| | - Nigel H. Lovell
- Graduate School of Biomedical Engineering, UNSW, Sydney, New South Wales, Australia
| | - Michael C. Stevens
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, the Prince Charles Hospital, Brisbane, Queensland, Australia
- Graduate School of Biomedical Engineering, UNSW, Sydney, New South Wales, Australia
- School of Medicine, University of Sydney, Camperdown, New South Wales, Australia
| | - Jo P. Pauls
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, the Prince Charles Hospital, Brisbane, Queensland, Australia
- School of Medicine, University of Queensland, Brisbane, Queensland, Australia
- School of Engineering, Griffith University, Brisbane, Queensland, Australia
| | - Rini Akmeliawati
- Department of Mechatronics Engineering, International Islamic University Malaysia, Kuala Lumpur
| | - Einly Lim
- Department of Biomedical Engineering, University of Malaya, Kuala Lumpur, Malaysia
- * E-mail:
| |
Collapse
|
37
|
Application of Adaptive Starling-Like Controller to Total Artificial Heart Using Dual Rotary Blood Pumps. Ann Biomed Eng 2016; 45:567-579. [DOI: 10.1007/s10439-016-1706-3] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2016] [Accepted: 08/04/2016] [Indexed: 11/24/2022]
|
38
|
Wang Y, Smith PA, Timms DL, Hsu PL, McMahon RA. In Vitro Evaluation of the Dual-Diffuser Design for a Reversible Rotary Intra-Aortic Ventricular Assist Device. Artif Organs 2016; 40:884-93. [DOI: 10.1111/aor.12746] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2015] [Revised: 02/01/2016] [Accepted: 03/04/2016] [Indexed: 12/23/2022]
Affiliation(s)
- Yaxin Wang
- Department of Engineering; University of Cambridge; Cambridge UK
| | | | | | - Po-Lin Hsu
- Artificial Organ Technology Laboratory; Soochow University; Suzhou China
| | | |
Collapse
|
39
|
Abstract
The aim of this work was to investigate the hemodynamic influence of the change of pump rate on the cardiovascular system with consideration of heart rate and the resonant characteristics of the arterial system when a reliable synchronous triggering source is unavailable. Hemodynamic waveforms are recorded at baseline conditions and with the pump rate of left ventricular assist device (LVAD) at 55, 60, 66, and 70 beats per minute for four test conditions in a mock circulatory system. The total input work (TIW) and energy equivalent pressure (EEP) are calculated as metrics for evaluating the hemodynamic performance within different test conditions. Experimental results show that TIW and EEP achieve their maximum values, where the pump rate is equal to the heart rate. In addition, it demonstrates that TIW and EEP are significantly affected by changing pump rate of LVAD, especially when the pump rate is closing to the natural frequency of the arterial system. When a reliable synchronous triggering source is not available for LVAD, it is suggested that selecting a pump rate equal to the resonant frequency of the arterial system could achieve better supporting effects.
Collapse
|
40
|
Gregory SD, Stevens MC, Wu EL, Pauls JP, Kleinheyer M, Fraser JF. Mitral Valve Regurgitation with a Rotary Left Ventricular Assist Device: The Haemodynamic Effect of Inlet Cannulation Site and Speed Modulation. Ann Biomed Eng 2016; 44:2674-82. [PMID: 26932840 DOI: 10.1007/s10439-016-1579-5] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2015] [Accepted: 02/24/2016] [Indexed: 11/29/2022]
Abstract
Mitral valve regurgitation (MVR) is common in patients receiving left ventricular assist device (LVAD) support, however the haemodynamic effect of MVR is not entirely clear. This study evaluated the haemodynamic effect of MVR with LVAD support and the influence of inflow cannulation site and LVAD speed modulation. Left atrial (LAC) and ventricular (LVC) cannulation was evaluated in a mock circulation loop with no, mild, moderate and severe MVR with constant speed and speed modulation (±600 RPM) modes. The use of an LVAD relieved pulmonary congestion during severe MVR, by reducing left atrial pressure from 20.5 to 10.8 (LAC) and 11.5 (LVC) mmHg. However, LAC resulted in decreased left ventricular stroke work (-0.08 J), ejection fraction (-7.9%) and higher MVR volume (+12.7 mL) and pump speed (+100 RPM) compared to LVC. This suggests that LVC, in addition to reducing MVR severity, also improves ventricular washout over LAC. LVAD speed modulation in synchrony with ventricular systole reduced MVR volume and increased ejection fraction with LAC and LVC, thus demonstrating the potential benefits of this mode, despite a reduction in cardiac output.
Collapse
Affiliation(s)
- Shaun D Gregory
- School of Medicine, University of Queensland, Brisbane, QLD, Australia.
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia.
| | - Michael C Stevens
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia
- Graduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, Australia
| | - Eric L Wu
- School of Medicine, University of Queensland, Brisbane, QLD, Australia
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia
| | - Jo P Pauls
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia
- School of Engineering, Griffith University, Southport, QLD, Australia
| | - Matthias Kleinheyer
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia
- School of Engineering, Griffith University, Southport, QLD, Australia
| | - John F Fraser
- School of Medicine, University of Queensland, Brisbane, QLD, Australia
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia
| |
Collapse
|
41
|
Physiological characterization of the SynCardia total artificial heart in a mock circulation system. ASAIO J 2016; 61:274-81. [PMID: 25551416 DOI: 10.1097/mat.0000000000000192] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
The SynCardia total artificial heart (TAH) has emerged as an effective, life-saving biventricular replacement system for a wide variety of patients with end-stage heart failure. Although the clinical performance of the TAH is established, modern physiological characterization, in terms of elastance behavior and pressure-volume (PV) characterization has not been defined. Herein, we examine the TAH in terms of elastance using a nonejecting left ventricle, and then characterize the PV relation of the TAH by varying preload and afterload parameters using a Donovan Mock Circulatory System. We demonstrate that the TAH does not operate with time-varying elastance, differing from the human heart. Furthermore, we show that the TAH has a PV relation behavior that also differs from that of the human heart. The TAH does exhibit Starling-like behavior, with output increasing via preload-dependent mechanisms, without reliance on an alteration of inotropic state within the operating window of the TAH. Within our testing range, the TAH is insensitive to variations in afterload; however, this insensitivity has a limit, the limit being the maximum driving pressure of the pneumatic driver. Understanding the physiology of the TAH affords insight into the functional parameters that govern artificial heart behavior providing perspective on differences compared with the human heart.
Collapse
|
42
|
Pauls JP, Stevens MC, Bartnikowski N, Fraser JF, Gregory SD, Tansley G. Evaluation of Physiological Control Systems for Rotary Left Ventricular Assist Devices: An In-Vitro Study. Ann Biomed Eng 2016; 44:2377-2387. [PMID: 26833037 DOI: 10.1007/s10439-016-1552-3] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2015] [Accepted: 01/13/2016] [Indexed: 11/25/2022]
Abstract
Rotary left ventricular assist devices (LVADs) show weaker response to preload and greater response to afterload than the native heart. This may lead to ventricular suction or pulmonary congestion, which can be deleterious to the patient's recovery. A physiological control system which optimizes responsiveness of LVADs may reduce adverse events. This study compared eight physiological control systems for LVAD support against constant speed mode. Pulmonary (PVR) and systemic (SVR) vascular resistance changes, a passive postural change and exercise were simulated in a mock circulation loop to evaluate the controller's ability to prevent suction and congestion and to increase exercise capacity. Three active and one passive control systems prevented ventricular suction at high PVR (500 dyne s cm(-5)) and low SVR (600 dyne s cm(-5)) by decreasing LVAD speed (by 200-515 rpm) and by increasing LVAD inflow cannula resistance (up to 1000 dyne s cm(-5)) respectively. These controllers increased LVAD preload sensitivity (to 0.196-2.415 L min(-1) mmHg(-1)) compared to the other control systems and constant speed mode (0.039-0.069 L min(-1) mmHg(-1)). The same three active controllers increased pump speed (600-800 rpm) and thus LVAD flow by 4.5 L min(-1) during exercise which increased exercise capacity. Physiological control systems that prevent adverse events and/or increase exercise capacity may help improve LVAD patient conditions.
Collapse
Affiliation(s)
- Jo P Pauls
- School of Engineering, Griffith University, Southport, QLD, Australia.
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia.
| | - Michael C Stevens
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia
- Graduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, Australia
| | - Nicole Bartnikowski
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia
- Science and Engineering Faculty, Queensland University of Technology, Brisbane, QLD, Australia
| | - John F Fraser
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia
- School of Medicine, University of Queensland, Brisbane, QLD, Australia
| | - Shaun D Gregory
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia
- School of Medicine, University of Queensland, Brisbane, QLD, Australia
| | - Geoff Tansley
- School of Engineering, Griffith University, Southport, QLD, Australia
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia
| |
Collapse
|
43
|
Gregory SD, Stevens MC, Pauls JP, Schummy E, Diab S, Thomson B, Anderson B, Tansley G, Salamonsen R, Fraser JF, Timms D. In Vivo Evaluation of Active and Passive Physiological Control Systems for Rotary Left and Right Ventricular Assist Devices. Artif Organs 2016; 40:894-903. [PMID: 26748566 DOI: 10.1111/aor.12654] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Preventing ventricular suction and venous congestion through balancing flow rates and circulatory volumes with dual rotary ventricular assist devices (VADs) configured for biventricular support is clinically challenging due to their low preload and high afterload sensitivities relative to the natural heart. This study presents the in vivo evaluation of several physiological control systems, which aim to prevent ventricular suction and venous congestion. The control systems included a sensor-based, master/slave (MS) controller that altered left and right VAD speed based on pressure and flow; a sensor-less compliant inflow cannula (IC), which altered inlet resistance and, therefore, pump flow based on preload; a sensor-less compliant outflow cannula (OC) on the right VAD, which altered outlet resistance and thus pump flow based on afterload; and a combined controller, which incorporated the MS controller, compliant IC, and compliant OC. Each control system was evaluated in vivo under step increases in systemic (SVR ∼1400-2400 dyne/s/cm(5) ) and pulmonary (PVR ∼200-1000 dyne/s/cm(5) ) vascular resistances in four sheep supported by dual rotary VADs in a biventricular assist configuration. Constant speed support was also evaluated for comparison and resulted in suction events during all resistance increases and pulmonary congestion during SVR increases. The MS controller reduced suction events and prevented congestion through an initial sharp reduction in pump flow followed by a gradual return to baseline (5.0 L/min). The compliant IC prevented suction events; however, reduced pump flows and pulmonary congestion were noted during the SVR increase. The compliant OC maintained pump flow close to baseline (5.0 L/min) and prevented suction and congestion during PVR increases. The combined controller responded similarly to the MS controller to prevent suction and congestion events in all cases while providing a backup system in the event of single controller failure.
Collapse
Affiliation(s)
- Shaun D Gregory
- School of Medicine, University of Queensland, Brisbane, Queensland, Australia. .,Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia.
| | - Michael C Stevens
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia.,School of Information Technology and Electrical Engineering, University of Queensland, Brisbane, Queensland, Australia
| | - Jo P Pauls
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia.,School of Engineering, Griffith University, Southport, Queensland, Australia
| | - Emma Schummy
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia
| | - Sara Diab
- School of Medicine, University of Queensland, Brisbane, Queensland, Australia.,Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia
| | - Bruce Thomson
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia
| | - Ben Anderson
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia
| | - Geoff Tansley
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia.,School of Engineering, Griffith University, Southport, Queensland, Australia
| | - Robert Salamonsen
- Department of Epidemiology and Preventative Medicine, Monash University, Melbourne, Victoria, Australia.,Intensive Care Unit, Alfred Hospital, Melbourne, Victoria, Australia
| | - John F Fraser
- School of Medicine, University of Queensland, Brisbane, Queensland, Australia.,Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia
| | | |
Collapse
|
44
|
A cardiovascular simulator tailored for training and clinical uses. J Biomed Inform 2015; 57:100-12. [DOI: 10.1016/j.jbi.2015.07.004] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2014] [Revised: 06/10/2015] [Accepted: 07/06/2015] [Indexed: 11/20/2022]
|
45
|
Pauls JP, Stevens MC, Schummy E, Tansley G, Fraser JF, Timms D, Gregory SD. In Vitro Comparison of Active and Passive Physiological Control Systems for Biventricular Assist Devices. Ann Biomed Eng 2015; 44:1370-80. [PMID: 26283049 DOI: 10.1007/s10439-015-1425-1] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2015] [Accepted: 08/10/2015] [Indexed: 11/29/2022]
Abstract
The low preload and high afterload sensitivities of rotary ventricular assist devices (VADs) may cause ventricular suction events or venous congestion. This is particularly problematic with rotary biventricular support (BiVAD), where the Starling response is diminished in both ventricles. Therefore, VADs may benefit from physiological control systems to prevent adverse events. This study compares active, passive and combined physiological controllers for rotary BiVAD support with constant speed mode. Systemic (SVR) and pulmonary (PVR) vascular resistance changes and exercise were simulated in a mock circulation loop to evaluate the capacity of each controller to prevent suction and congestion and increase exercise capacity. All controllers prevented suction and congestion at high levels of PVR (900 dynes s cm(-5)) and SVR (3000 dynes s cm(-5)), however these events occurred in constant speed mode. The controllers increased preload sensitivity (0.198-0.34 L min(-1) mmHg(-1)) and reduced afterload sensitivity (0.0001-0.008 L min(-1) mmHg(-1)) of the VADs when compared to constant speed mode (0.091 and 0.072 L min(-1) mmHg(-1) respectively). The active controller increased pump speeds (400-800 rpm) and pump flow by 2.8 L min(-1) during exercise, thus increasing exercise capacity. By reducing suction and congestion and by increasing exercise capacity, the control systems presented in this study may help increase quality of life of VAD patients.
Collapse
Affiliation(s)
- Jo P Pauls
- School of Engineering, Griffith University, Southport, QLD, Australia. .,Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia.
| | - Michael C Stevens
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia.,School of Information Technology and Electrical Engineering, University of Queensland, Brisbane, QLD, Australia
| | - Emma Schummy
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia
| | - Geoff Tansley
- School of Engineering, Griffith University, Southport, QLD, Australia.,Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia
| | - John F Fraser
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia.,School of Medicine, University of Queensland, Brisbane, QLD, Australia
| | - Daniel Timms
- Center for Technology Innovation, Texas Heart Institute, Houston, TX, USA.,BiVACOR Inc., Houston, TX, USA
| | - Shaun D Gregory
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia.,School of Medicine, University of Queensland, Brisbane, QLD, Australia
| |
Collapse
|
46
|
Misgeld BJ, Rüschen D, Schwandtner S, Heinke S, Walter M, Leonhardt S. Robust decentralised control of a hydrodynamic human circulatory system simulator. Biomed Signal Process Control 2015. [DOI: 10.1016/j.bspc.2015.04.004] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
47
|
Nestler F, Bradley AP, Wilson SJ, Timms DL, Frazier OH, Cohn WE. A hybrid mock circulation loop for a total artificial heart. Artif Organs 2015; 38:775-82. [PMID: 25234760 DOI: 10.1111/aor.12380] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Rotary blood pumps are emerging as a viable technology for total artificial hearts, and the development of physiological control algorithms is accelerated with new evaluation environments. In this article, we present a novel hybrid mock circulation loop (HMCL) designed specifically for evaluation of rotary total artificial hearts (rTAH). The rTAH is operated in the physical domain while all vasculature elements are embedded in the numerical domain, thus combining the strengths of both approaches: fast and easy exchange of the vasculature model together with improved controllability of the pump. Parameters, such as vascular resistance, compliance, and blood volume, can be varied dynamically in silico during operation. A hydraulic-numeric interface creates a real-time feedback loop between the physical and numerical domains. The HMCL uses computer-controlled resistance valves as actuators, thereby reducing the size and number of hydraulic elements. Experimental results demonstrate a stable interaction over a wide operational range and a high degree of flexibility. Therefore, we demonstrate that the newly created design environment can play an integral part in the hydraulic design, control development, and durability testing of rTAHs.
Collapse
Affiliation(s)
- Frank Nestler
- School of Information Technology and Electrical Engineering, The University of Queensland, St. Lucia; ICET Lab, Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia; The Texas Heart Institute, Houston, TX, USA
| | | | | | | | | | | |
Collapse
|
48
|
Lo C, Gregory S, Stevens M, Murphy D, Marasco S. Banding the Right Ventricular Assist Device Outflow Conduit: Is It Really Necessary With Current Devices? Artif Organs 2015; 39:1055-61. [PMID: 25994563 DOI: 10.1111/aor.12497] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Implantable left ventricular assist devices (LVADs) have been adapted clinically for right-sided mechanical circulatory support (RVAD). Previous studies on RVAD support have established the benefits of outflow cannula restriction and rotational speed reduction, and recent literature has focused on assessing either the degree of outflow cannula restriction required to simulate left-sided afterload, or the limitation of RVAD rotational speeds. Anecdotally, the utility of outflow cannula restriction has been questioned, with suggestion that banding may be unnecessary and may be replaced simply by varying the outflow conduit length. Furthermore, many patients have a high pulmonary vascular resistance (PVR) at the time of ventricular assist device (VAD) insertion that reduces with pulmonary vascular bed remodeling. It is therefore important to assess the potential changes in flow through an RVAD as PVR changes. In this in vitro study, we observed the use of dual HeartWare HVAD devices (HeartWare Inc., Framingham, MA, USA) in biventricular support (BiVAD) configuration. We assessed the pumps' ability to maintain hemodynamic stability with and without banding; and with varying outflow cannulae length (20, 40, and 60 cm). Increased length of the outflow conduit was found to produce significantly increased afterload to the device, but this was not found to be necessary to maintain the device within the manufacturer's recommended operational parameters under a simulated normal physiological setting of mild and severe right ventricular (RV) failure. We hypothesize that 40 cm of outflow conduit, laid down along the diaphragm and then up over the RV to reach the pulmonary trunk, will generate sufficient resistance to maintain normal pump function.
Collapse
Affiliation(s)
- Casey Lo
- Sir Charles James Officer Brown Department of Cardiothoracic Surgery, The Alfred Hospital, Prahran, Victoria, Australia
| | - Shaun Gregory
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia.,School of Medicine, The University of Queensland, Brisbane, Queensland, Australia
| | - Michael Stevens
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia
| | - Deirdre Murphy
- Cardiothoracic Intensive Care Unit, The Alfred Hospital, Prahran, Victoria, Australia
| | - Silvana Marasco
- Sir Charles James Officer Brown Department of Cardiothoracic Surgery, The Alfred Hospital, Prahran, Victoria, Australia
| |
Collapse
|
49
|
Rezaienia MA, Rahideh A, Alhosseini Hamedani B, Bosak DEM, Zustiak S, Korakianitis T. Numerical and In Vitro Investigation of a Novel Mechanical Circulatory Support Device Installed in the Descending Aorta. Artif Organs 2015; 39:502-13. [DOI: 10.1111/aor.12431] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
| | - Akbar Rahideh
- School of Electrical and Electronic Engineering; Shiraz University of Technology; Shiraz Iran
| | | | | | - Silviya Zustiak
- Parks College of Engineering, Aviation and Technology; Saint Louis University; St. Louis MO USA
| | - Theodosios Korakianitis
- Parks College of Engineering, Aviation and Technology; Saint Louis University; St. Louis MO USA
| |
Collapse
|
50
|
In vitro evaluation of an ultrasonic cardiac output monitoring (USCOM) device. J Clin Monit Comput 2015; 30:69-75. [PMID: 25749977 DOI: 10.1007/s10877-015-9685-8] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2014] [Accepted: 02/27/2015] [Indexed: 12/22/2022]
Abstract
Non-invasive cardiac output monitoring techniques provide high yield, low risk mechanisms to identify and individually treat shock in the emergency setting. The non-invasive ultrasonic cardiac output monitoring (USCOM) device uses an ultrasound probe applied externally to the chest; however limitations exist with previous validation strategies. This study presents the in vitro validation of the USCOM device against calibrated flow sensors and compares user variability in simulated healthy and septic conditions. A validated mock circulation loop was used to simulate each condition with a range of cardiac outputs (2-10 l/min) and heart rates (50-95 bpm). Three users with varying degrees of experience using the USCOM device measured cardiac output and heart rate by placing the ultrasound probe on the mock aorta. Users were blinded to the condition, heart rate and cardiac output which were randomly generated. Results were reported as linear regression slope (β). All users estimated heart rate in both conditions with reasonable accuracy (β = 0.86-1.01), while cardiac output in the sepsis condition was estimated with great precision (β = 1.03-1.04). Users generally overestimated the cardiac output in the healthy simulation (β = 1.07-1.26) and reported greater difficulty estimating reduced cardiac output compared with higher values. Although there was some variability between users, particularly in the healthy condition (P < 0.01), all estimations were within a clinically acceptable range. In this study the USCOM provided a suitable measurement of cardiac output and heart rate when compared with our in vitro system. It is a promising technique to assist with the identification and treatment of shock.
Collapse
|